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Summary of thesis 
 
 
Three papers are presented as a thesis for partial fulfilment for the Doctorate in Clinical Psychology 
(DClinPsy).  The first two are presented as papers for submission to the Journal of Autism and 
Developmental Disorders (JADD), which presents papers related to Autism Spectrum Disorders 
(ASD) and Developmental Disabilities.  The third paper is a reflective paper on the process of 
undertaking the former two.  This is not prepared for publication. 
 
Paper 1 is a systematic review of the methodological quality of extant research of ‘co-morbid’ Autism 
Spectrum Disorder in children and young people with Fragile X Syndrome.  It reviews 13 
methodologically sound peer reviewed papers and presents a qualitative synthesis of findings.  The 
synthesis highlights the direction of impairment of particular ASD behavioural phenotypes and a 
trajectory model for the development of ASD traits in FXS. 
 
Paper 2 presents an empirical study of gender differences in FXS and comorbid FXS and ASD 
(FXS+ASD) presentations, also considering the impact of intellectual disability.  The study utilised an 
online platform and accessed participants via the Fragile X Society database.  Participants were parents 
of children with a diagnosis of FXS.  They completed a series of questionnaire measures, which 
indicated the sample did not differ significantly according to gender; severity of ASD traits was not 
associated with cognitive ability; and the presence of ASD traits increased with age.  The latter finding 
supported the trajectory model suggested in Paper 1. 
 
Paper 3 provides a considered critique and reflective evaluation of the process of undertaking the 
previous papers.  It provides a personal iterative reflection into the impact of the author’s prior 
experiences and the impact of these on the direction of the research thesis.  As well as additional 
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reflection on challenges and limitations of the research process; cumulating in highlighting the 
transformative nature of the research process and the plan for dissemination of findings. 
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Abstract  
 
Background: To evaluate whether the high percentage of individuals with Fragile X Syndrome (FXS) 
who demonstrate comorbid Autism Spectrum Disorder (ASD) symptoms display behavioural 
phenotypes (BPs) of a categorically distinct disorder to FXS.   
 
Methods: A literature search of MEDLINE, PsychINFO and Embase was conducted of English 
language, peer reviewed journals.  Studies of the BP of FXS in participants aged 0-25years, with a 
genetically confirmed presentation of FXS and a clinically diagnosed ASD control or reference group 
were included.      
 
Results: Thirteen studies were reviewed (n=1,319) that considered research questions exploring the 
BP of FXS and ASD.  Study design included longitudinal, as well as cross sectional cohort studies, 
assessing gender differences, intellectual ability, presentation of early infants and older children.   
 
Discussion: A distinction between FXS and FXS with comorbid ASD exists.  This is proposed to be 
on a continuum of impairment, the direction of impairment depends on the individual BP, and has been 
termed FXS+.  A trajectory model of development is supported.       
 
Key words: Fragile X Syndrome; FXS; Autism Spectrum Disorder; ASD; children; comorbid  
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Introduction 
 
People with Fragile X Syndrome (FXS) often present with autistic traits (Hagerman et al., 1986).  
However, there is no consensus as to whether Autism Spectrum Disorder (ASD) in FXS is 
categorically distinct (Cornish, Turk & Levitas, 2007; Hall., Lightbody, Hirt, Rezvani, & Reiss, 2010; 
Abbeduto, McDuffie & Thurman, 2014).  A comorbid perspective is that symptoms of autism in FXS 
share the same underlying neurological and psychological dysfunctions as idiopathic ASD (iASD). 
Alternatively, a continuum view holds that ASD in FXS is the complex and severe end of the FXS 
range of impairment. To understand these discrepancies distinction between the genetically diagnosed 
FXS and behaviourally diagnosed ASD is paramount (Halle et al., 2010).   
 
Patterns of behaviour that present in syndromes caused by chromosomal or genetic differences are 
termed behavioural phenotypes (BP). They are characterised by patterns of social, linguistic, cognitive 
and motor observations, reliably associated with biological or genetic disorders (O’Brien, 2006).  
Charting complex phenotypical and developmental trajectories can help identify markers of shared 
aetiology and advance insight into underlying cognitive, neurological and genetic mechanisms; and 
clarify direct clinical and theoretical implications (Lee, Martin, Berry-Kravis, & Losh, 2016).  
 
Confirmation of BPs is beneficial for recognition, diagnosis, early intervention and evaluation (Cross 
& Hare, 2013). In FXS delineating BP is theorised to determine how behaviour, genes and cognitive 
function interact in FXS (Dykens, 2000) and improve understanding of the mechanisms behind 
genotype expression.  Thus, it provides valuable research data for clinical practice in areas such as 
self-harm, social anxiety, sensory differences, social skills, emotional disturbances and repetitive 
behaviours (Waite et al., 2014). Recent research into FXS and ASD has progressed and through 
exploration of the behavioural phenotype, potential differences are emerging (Daffin, Thomas, 
Hardiman & Hare; In Submission). 
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Fragile X syndrome 
 
Pre or postnatal genetic testing provides diagnosis of pre-mutation or full mutation FXS.  FXS is the 
most commonly known cause of inherited intellectual disability (Turner, Webb, Wake, & Robinson, 
1996; Crawford, Acuña, & Sherman, 2001), affecting approximately 1 in 4,000 males and 1 in 6,000 
females (Boyle & Kaufmann, 2010).  FXS results from a cytosine-guanine-guanine (CGG) expansion 
that triggers hyper-methylation and silencing of the FMR1 on the X chromosome at Xq27.3.  This 
creates a direct correlation in the number of CGG repeats in the sequence and informs severity of the 
phenotype.  The expansion leads to a decrease or absence of the fragile X mental retardation protein 
(FMRP) produced by the FMR1 gene. Expansions in the 60–200 repeat status, termed pre-mutation or 
individuals termed carriers, do not significantly affect the transcription of FMRP. But expansions 
above 200 CGG repeats lead to the full mutation in their offspring (O’Brien, 2006).  
 
Individuals with the FMR1 pre-mutation do not generally have the same BP as full mutation FXS 
(Boyle & Kaufmann, 2010). As X-linked disorder, males with FXS tend to be more impaired than 
females due to females having one X chromosome that carries a healthy FMR1 allele. Nearly all males 
with FXS will have an intellectual disability (ID) but only a third of females (Hagerman et al., 2009; 
Gallagher & Hallahan, 2012; Crawford, Moss, Anderson, Oliver & McCleery, 2015). Males with FXS-
O (FXS without co-morbid ASD) generally present with mild ID (Full Scale IQ; FSIQ 55-70), whereas 
males with co-morbid FXS+ASD usually have moderate ID, FSIQ 40-54 (Boyle & Kaufmann, 2010).  
Hardiman and Bratt (2016) have begun to explore the prevalence of stress-related circuits that may 
inform the BP of FXS presenting as exaggerated behavioural responses to stressors.  Consequently, 
the hypothalamic-pituitary adrenal (HPA) axis, a stress effector system that triggers the release of 
cortisol, is hypothesised to be an important agent in social and psychological behaviours. Given the 
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close association between FXS and ASD, it is suggested that children with ASD experience increased 
cortisol response to stress (Corbett, Mendoza, Abdullah, Wegelin, & Levine, 2006; Spratt et al., 2012) 
and that reduced FMRP may result in excessive activation of HPA axis (Hessl et al., 2002).  
Exploration of the role of HPA axis in the development of a BP in FXS has gathered evidence for the 
efficacy that cortisol levels differ in FXS compared to typically developing (TD) controls (Hardiman 
& Bratt. 2016).  Cordeiro, Ballinger, Hagerman and Hessl (2011) report 86% of individuals with FXS 
have an anxiety disorder, with comorbid anxiety leading to increased impairment. 
 
Autism spectrum disorder 
 
Autism spectrum disorder is characterised by difficulty in communication, reciprocal social interaction 
and restrictive, repetitive stereotyped behaviours (American Psychiatric Association, 2013). National 
Institute of Health and Clinical Excellence (NICE, 2011; updated 2017) guidance recommends that 
diagnosis of ASD is made according to the Diagnostic Statistics Manual (DSM-V; American 
Psychiatric Association, 2013) or International Classification of Diseases version 10 (ICD10; World 
Health Organization, 1992) criteria.  NICE indicate a gold standard assessment should include 
standardised measures such as the Autism Diagnosis Observation Schedule (ADOS; Lord et al., 1989; 
Lord et al, 2000); the Autism Diagnostic Interview – Revised (ADI-R; Lord et al. 1994); or the 
Diagnostic Instrument for Social and Communication Disorders (DISCO; Wing, Leekam, Libby, 
Gould, & Larcombe, 2002).   
 
Many children with FXS typically present with marked behavioural features that can include attention 
deficits; hyperactivity; hyper arousal; anxiety; repetitive behaviours/interests, vocalisations and 
gestures; social difficulties and gaze avoidance similar to those observed in children diagnosed with 
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iASD.  Consequently, the assessment of comorbid ASD in children with FXS is increasingly 
undertaken (Hall, et al., 2010).  
 
 
Relationship between FXS and ASD 
 
Evidence that certain individuals with genetic and metabolic syndromes might have an atypical profile 
of ASD phenomenology is emerging, supporting a distinction between syndromic variants of ASD and 
iASD (Moss & Howlin, 2009; Hall, Lightbody, Hirt, Rezvani, & Reiss, 2010).  More than 90% of 
males with FXS display behaviours that are similar to those observed in individuals with iASD (Bailey, 
Hatton, Mesibov, Ament & Skinner, 2000). Feinstein and Reiss (1998) proposed that there may be a 
genetic explanation for this, with a genetically distinct subgroup of individuals with FXS.   Despite 
this, only a small portion meet full DSM-IV criteria for autistic disorder (Budimirovic and Kaufmann, 
2011) and only 25% of girls and boys receive a diagnosis in clinical practice (Klusek, Martin & Losh, 
2014). As the presence and degree of ASD symptoms differs, considerable variability is observed in 
the behavioural phenotype of FXS (Abbeduto, McDuffie & Thurman, 2014). ASD is heterogenous in 
nature, confounding assessment and formulation of specific phenotypical behaviour and subsequent 
diagnosis. Furthermore, cognitive abilities are more limited in individuals with FXS than in individuals 
with iASD, with more than 90% of males with FXS having an IQ in the range of ID (Hessl et al., 
2009). UK rates of ASD are around 1 in 100 (Baird et al., 2006) and 1-68 in the USA (Baio, 2014). 
Prevalence rates of FXS individuals proposed to have comorbid ASD fluctuate in research findings 
from: 21-51% (Moss & Howlin, 2009); 22-33% (Zafeiriou, Ververi, Dafoulis, Kalyva, & Vargiami, 
2013) and 30% (Richards, Jones, Groves, Moss, & Oliver, 2015).   
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Research into co-morbid ASD and FXS has historically recruited individuals with a prior diagnosis of 
ASD, FXS, or co-morbid diagnosis. The ADOS and ADI-R are diagnostic tools but may not provide 
the sensitivity to understand individual difference in FXS as they are not measuring severity of 
symptomology. They were not designed, normed or calibrated for FXS and lack specificity in 
syndrome variances. For instance, in a sample of 63 boys with FXS (aged 2-19) only 24% of the 
sample met the diagnostic criteria for ASD on ADOS and ADI-R measures and DSM-IV criterion, 
whereas an additional 44% met the criteria on one or two of the three measures (Harris et al., 2008), 
thus highlighting the difficulties in applying dichotomous and phenomenologically defined diagnoses 
to behaviours and symptoms that vary throughout a developmental trajectory (Hall et al., 2010). 
 
FXS with co-morbid conditions appears to increase the quantity and severity of phenotypic behaviours 
and is associated with lower parental estimates of their child’s Quality of Life (QoL; Bailey, Raspa, 
Olmsted & Holiday, 2008). Hagerman et al. (2017) report an extensive set of studies that present highly 
related co-occurring issues that if addressed could improve QoL. These include: psychosocial 
characteristics such as anxiety, ASD symptoms, self-injury and aggression; health problems such as 
seizures and sleep deprivation; reduced cognitive and executive functioning; and social isolation due 
to poor functional and adaptive behaviour.  
 
The aim of the current review is to systematically explore the methodological quality and findings of 
extant research examining BP of ‘co-morbid’ ASD in children and young people with FXS.  In 
examining the BP, support for either comorbid disorder or continuum hypotheses may emerge.  This 
may provide fundamental information regarding the diagnosis and intervention requirements within 
this group.  
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Method 
 
 
Search strategy 
 
MEDLINE (1946) PsychINFO (1806-) Embase (1947-) databases were searched for relevant articles 
in October 2018.  Searches were limited to those published in English, peer-reviewed journals and 
empirical study.   The following search terms were used with Boolean operators and truncation as 
indicated, to search in title or abstract: Fragile X Syndrome, fragile x syndrome,. Fxs, “AND” Autism 
Spectrum Disorders, autism spectrum disorder*, asd, autism, Aspergers syndrome.  Followed by a 
search in all fields for one of: phenotype “OR” phenotypes, behaviour*, children, adolescents, 
comorbid. intellectual disabilit*“OR” learning disability*. 
 
 
Selection criteria 
 
The inclusion criteria were: studies of BP of FXS; study participants with FXS provided evidence of 
genetic testing and participants with ASD had received a clinical diagnosis (confirmed by the study); 
papers included participants with FXS, or FXS with comorbid ASD; the maximum age of participants 
was 25 (to match the current education provision range); papers published after 2000 were included; 
empirical study.  The exclusion criteria were: studies focussing on premutation only; single participant 
case studies; animal studies; studies researching medication intervention only. 
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Search results 
 
PRISMA Flow Diagram 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 PRISMA flow-chart 
 
The PRISMA flow-chart (Figure 1) demonstrates the filtering process of the 377 papers returned by 
the original search, 216 abstracts were retrieved after removal of duplicates, limiting to English 
Records identified through 
database searching 
(n = 377) 
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en
in
g  
In
cl
ud
ed
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Id
en
tif
ic
at
io
n 
Additional records identified 
through other sources 
(n = 3) 
Records after duplicates removed and those 
not in English 
(n = 261) 
Records screened 
(n = 216) 
Records excluded (n = 165) 
-Animal studies (n = 25) 
-Review papers (n = 8) 
-Systematic reviews (n = 7) 
-Opinion papers (n = 7) 
-Not BP of FXS (n = 118)  
 
Full-text articles assessed 
for eligibility 
(n = 51) 
Full-text articles excluded (n=28) 
-BP intervention 
-Pharmaceutical BP intervention  
-Adults over 25 
 Studies included in 
qualitative synthesis 
(n = 23) 
Studies included in 
quantitative synthesis 
(n = 13) 
Full-text articles excluded (n=10) 
-No iASD ref or comparison 
group 
-Articles before 2000 
-Poor methodological quality 
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language and human studies. Following analysis of abstract, 51 papers were retrieved in full and further 
papers were retrieved from hand searches of these references.  
 
 
Data extraction and scoring 
 
 
Two independent assessors ratified all papers for quality using an adapted version of Cross and Hare’s 
(2013) generic tool to review and score the quality of studies assessing BP (see Appendix B). In total, 
23 papers were screened for methodological quality and specificity (see Appendix C).  
 
An additional criterion was applied to exclude studies that didn’t compare FXS to an ASD control or 
normative data for individuals with ASD e.g. ADOS or ADI-R, resulting in 13 studies for review. 
Papers that scored ≥ 9 were deemed to warrant inclusion.  
 
 
Methodology 
 
Papers for review (N=13) were then scored for methodological quality, summarised in Table 1.  
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Table 1: Summary of methodological quality of selected review papers. 
Author/ 
Year/ Score 
Study Aims Control 
Group 
Sample 
Size 
(age 
range) 
Recruit
ment 
Diag
nosis 
Methodol
ogy 
Develop
mental 
Factors  
Stats Findings 
 
1.Hall et al. 
2010 
Determine 
appropriateness of 
comorbid ASD 
diagnosis in boys 
and girls with 
FXS. 
FXS (n=120) 
 
ND 
N=120 
(47F/73
M) 
AR=5-
25 
MC SBT 
ADO
S 
S/VM SA  DS, 
BC, 
WC 
Y*  
OR 
35% boys and 4.31% girls with FXS scored on the 
ASD category on SCQ and ADOS; poor agreement 
between measures.  Significant differences in profile 
of ASD symptoms in FXS+ASD compared to norms 
for ASD.  (FXS+ASD=High levels of social 
avoidance, repetitive behaviours & language, but 
less impaired than IA). IQ significantly negatively 
associated with SCQ. 
12/14  1 2 2 2 1 2 2  
2. Hernandez 
Feinberg, 
Vaurio, 
Passanante, 
Thompson, & 
Kaufmann, 
2009 
Stability of 
FXS+ASD & 
cognitive ability 
over time 
FXS + (n=24 
at baseline) 
 
FXS (n=32 
at baseline) 
Time 1: 
N=56 
AR=30
-88 
months  
Time 2: 
(n=44) 
Time 3: 
n=34) 
SC  SBT 
 
ADI-
R 
S/VM 
 
LS DS, 
BC, 
WC 
Y* 
 
Diagnosis of FXS+ASD stable over time, with 
behaviours linked to peer relationships & 
socialisation adaptability.  Reciprocal Social 
Interaction (Recs) only domain to distinguish 
FXS+ASD vs FXS at all time points.   
Increased severity in FXS and reduced severity in 
FXS+ASD over time meant that differentiation 
between the two was harder.   FXS+ASD IQ scores 
were stable over time, but FXS Verbal IQ decreased 
over time. 
12/14  1 2 1 2 2 2 2  
3.Kau et al., 
2004 
 
Social behaviour 
profile (SBP) of 
boys with FXS, 
and effect of age 
FXS (n=41) 
FXS+ASD 
(n=14) 
DLD with 
ASD; (n 22) 
iASD (n=11) 
N=88 
AR=3-
8 
 
 
MC 
 
GT 
SBT 
 
ADI-
R 
S/VM 
 
AM 
(FXS / 
DLD + 
ASD) 
DS,  
BC 
WC 
Y* 
 
FXS+ASD is a distinctive sub-phenotype in boys 
with FXS.   
13/14  2 2 2 2 1 2 2  
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4.Klusek, G. 
E. Martin & 
M. Losh 
(2014) 
Whether boys and 
girls with FXS 
met criteria for 
ASD using 
ADOS/ADI 
FXS (n=86) 
ND 
N= 86 
(35 F / 
51M) 
AR 
M/SD 
MC NS 
 
ADO
S/AD
I-R 
S/VM 
 
CI 
OM 
SA DS, 
WC 
Y* 
OR  
43% sample met criteria for ASD using ADOS & 
ADI-R.  ADOS/ADI-R agreed 76.5%.  56% 
caregiver reported diagnosis agreed with 
ADOS/ADI-R. 
ASD may be under diagnosed in clinical settings. 
11/14  1 2 2 0 2 2 2  
5.Lee, Martin, 
Berry-Kravis, 
& Losh, 2016 
BP change over 
development 
(mean 2.5 years) 
in boys & girls 
with FXS. 
FXS (31 M; 
34 F) 
ASD-O (19 
M) 
N=84 
NS 
M/SD 
 
MC NS  
 
ADO
S/AD
I-R  
S/VM 
 
 
SA 
 
DS, 
WC, 
BC 
Y* 
 
ASD symptoms increased in FXS with age; social 
language impairment emerged as a potential core 
shared feature of FXS and ASD. 
12/14  2 2 2 0 2 2 2  
6.Martin, 
Bush, Klusek, 
Patel, & Losh, 
2018 
 
 
language sample 
analysis of 
syndrome and 
sex-specific 
profiles  
FXS+ASD 
n=61  
FXS n=40  
DS n=42  
TD n=37  
ASD n=29  
N=209 
NS 
M/SD 
MC GT 
 
ADO
S 
 
S/VM 
OM  
 
SA WC, 
BC 
Y* 
ES 
Non-continent language and perseveration were 
characteristics of the pragmatic profiles of boys and 
girls with FXS+ASD and boys with ASD.  Boys 
with ASD initiated turns less often and were more 
non-responsive than other groups; girls with 
FXS+ASD were more non-responsive than male 
counterparts. 
14/14  2 2 2 2 2 2 2  
7.McDuffie, 
Thurman, 
Hagerman, & 
Abbeduto, 
2015 
Which symptoms 
of ASD differed 
in boys with FXS 
relative to same 
aged boys with 
ASD. 
FXS n=57 
 
ASD n=61 
N= 118 
 
AR=4-
10 
 
MC GT 
ADI-
R/AD
OS 
GS  
S/VM 
 
 
 
 
AM DS, 
BC 
Y* 
ES 
Boys with FXS show significantly less impairment 
in social smiling than did age, severity and 
diagnostic boys with iASD. Severity matched boys 
with FXS showed more impairment in complex 
mannerisms than boys with iASD. 
13/14  2 2 2 2 1 2 2  
8.Roberts et 
al., 2018 
 
Social anxiety and 
FXS and 
association with 
ASD;  
FXS n=59 
(broken 
down to 
FXS and 
FXS+ASD 
for analysis) 
ASD n=18 
N=77  
AR=15
-23  
MC GT 
ADO
S/AD
I-R 
GS 
S/VM 
  
BCL 
 
SA DS,B
C 
Y* 
ES 
Salivary cortisol appears to be a marker of general 
disrupted arousal rather than specific indicator of 
social avoidance. 
Difference between FXS and FXS+ASD males; 
FXS had initial social avoidance; FXS+ASD has 
prolonged social avoidance. 
14/14  2 2 2 2 2 2 2  
9.Rogers, 
Wehner, & 
Hagerman, 
2001) 
 
 
Symptoms of 
ASD and 
relationships 
between ASD 
symptoms and 
developmental 
FXS (n=16) 
FXS+ASD 
(n=8) 
ASD (n=27) 
Other 
development
N=74 
AR: 21 
–48 
months 
MC GT 
 
ADI-
R/AD
OS. 
 
S/VM:  
 
Compare
d ‘en 
masse’ 
 
DS 
BC 
Y* 
FXS group composed of 2 subgroups (FXS-O vs. 
FXS+ASD) prompting hypothesis for a genetic 
distinction. 
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variables in young 
children with FXS 
al delays 
(n=23)  
 
11/14  2 2 2 2 1 0 2  
10.Thurman, 
McDuffie, 
Hagerman, & 
Abbeduto, 
2014) 
Examine 
psychiatric 
symptoms in boys 
with fragile FXS 
using a parent 
report instrument.  
FXS (n= 41) 
ASD (n=41)   
N=82 
AR=4.
02-
10.99 
 
 
 
MC (2) 
 
GT 
 
ADO
S 
GS 
 
 
S/VM:  
 
  
 
 
AM 
(Sub-
group 
n=30)  
DS 
WR 
BC 
Y* 
ES 
 
Symptoms of hyperactivity and general anxiety 
more frequent for FXS than ASD. Also positive 
association between social avoidance and general 
anxiety in FXS not found in ASD. 
12/14  2 2 2 2 1  1 2  
11.Thurman, 
McDuffie, 
Kover, 
Hagerman, & 
Abbeduto, 
2015a 
Compare profiles 
of ASD relative to 
age (CA), 
nonverbal IQ, and 
expressive 
vocabulary ability 
between FXS and 
iASD  
FXS (n=12) 
FXS+ASD 
(n=41) 
ASD (n=39) 
 
N= 92 
AR=4-
11  
MC (2) DPG
T  
ADO
S/AD
I-R  
GS 
S/VM:  
 
 
 
 
AM 
NVIQM 
EVAM 
DS 
BC 
Y* 
ES 
 
Onset of ASD symptoms and developmental 
trajectories in males with FXS differ as a function of 
CA, nonverbal cognitive ability, and expressive 
vocabulary relative to males with iASD. 
13/14  2 2 2 2 1 2 2  
12.Thurman, 
McDuffie, 
Kover, 
Hagerman, & 
Abbeduto, 
2015b 
Evaluate the 
ability of males 
with FXS, ASD & 
typical 
development to 
learn new words 
by using cue 
FXS (n = 32) 
ASD (n = 
32)  
 TD (n = 32) 
 
N=172 
AR=2.
05 –
10.86 
 
 
MC (2) DPG
T  
 
ADO
S/AD
I-R  
GS 
S/VM 
 
OM 
(successful
/ 
unsuccessf
ul search 
condition) 
SA DS 
BC 
WC 
Y* 
ES 
 
 
 
Successful search condition:  iASD performed 
similarly to FXS controlling for severity of ASD. 
Unsuccessful search condition: FXS performed 
significantly worse than iASD, controlling for 
severity of ASD.  
14/14  2 2 2 2 2 2 2  
13. Wolff. 
Bodfish, 
Hazlett, 
Lightbody, 
Reiss, & 
Piven, 2012 
Similarities and 
differences in 
behavioural 
expression of 
autism in FXS 
and iAut. 
FXS (n=23) 
 
IA (n=38) 
N=61 
AR=3-
5 
MC GT 
 
ADO
S/AD
I-R 
S/VM 
 
AM DS 
 
BC  
Y* 
ES  
Findings indicate phenotypical heterogeneity of 
autism in its unique presentation in FXS. 
13/14  2 2 2 2 1 2 2  
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Key for table 
 
NS= Not specified.  
Control group: FXS+ASD = Fragile X Syndrome and Autism Spectrum Disorder. ASD = Autism Spectrum Disorder. IA= Idiopathic Autism. DLD=Developmental 
Language Delay. TD = Typically developing. DS = Downs Syndrome. ND = normative data 
Sample size: AR= Age range. M/SD = M/SD reported 
Recruitment: SC-=Single clinic or diagnostic centre. MC= Main diagnostic clinic or multiple clinics / centres 
Syndrome diagnosis / ASD diagnosis based on: GT=Genetic testing. DPGT = Document of proof for genetic testing. ADI-R = Autism Diagnostic Interview Revised (ADI-
R). ADOS = Autism Diagnostic Observation Scales (ADOS) / ADOS 2. GS = Genetic screening (to rule out FXS)   
Methodology: CI=Clinical interview. BCL=-Baseline cortisol level. OM=Other methodology. S/VM=Standardised/Validated measures 
Developmental Factors: LS=Longitudinal study. AM=Age Matched Control. NVIQM=Non-verbal IQ matched. EVAM=Expressive vocabulary ability. SA=Accounted for 
by statistical analysis 
Statistics: DS=Descriptive statistics/percentages. WC=Within syndrome comparative statistics. WR=Within syndrome correlations. BC=Comparative statistics between 
syndrome and genetically distinct control group. Y/N (*) = sig. diff. found from genetically distinct control / repeated measures Y/N ES = Effect size reported  
OR = Odds ratio reported  
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Findings 
 
All studies were rated as being of good methodological quality and so were reviewed in more 
detail.  The findings of this review were grouped according to aspects of the behavioural 
phenotype, as well as IQ, with comparisons made between findings, reference to methodology and 
limitations highlighted.   
Social Interaction 
 
A diagnosis of ASD in FXS was relatively stable over time, with prominent behaviours linked to 
peer relationships, socialisation adaptability and social withdrawal behaviours mainly informing 
ASD diagnosis.  Reciprocal Social Interaction was the only domain to distinguish FXS+ASD from 
FXS, being significantly more impaired, at all-time points  (Hernandez et al. 2009).   
 
Lee et al. (2016) indicated similarities on specific symptoms between ASD and FXS+ASD group 
at time point one, which are not demonstrated in FXS.  Significant differences in facial expressions 
and social overtures, were found, with FXS less impaired than FXS+ASD, who were less impaired 
than ASD.  
 
Contrary to previous research (e.g. Hatton et al., 2006; Hernandez et al., 2009) ASD symptoms in 
FXS increased with age. Social language impairment emerged as a potential core shared feature 
of FXS and ASD. The greatest overlap was that of reciprocal social communication of boys with 
FXS+ASD when compared with boys with iASD.  Thurman et al. (2015a) found that social 
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affective symptoms of ASD were significantly fewer in boys with FXS compared to iASD at age 
four; severity of symptoms increased with age for the FXS group, consistent with Hall et al (2010) 
and Lee et al (2016). Symptom severity is not considered to be age related and so indicates a 
tangible change over time.  A significant between group difference emerged with severity of social 
affect minimally affected by age, nonverbal IQ and expressive language ability in iASD 
contrasting with that for children with FXS; support for the finding was reported in Kau et al. 
(2004) and Lee et al. (2016).   
 
Specific differences were highlighted by Hall et al. (2010) with both genders with FXS indicating 
lower impairment on communication and reciprocal social interaction items than the referenced 
ASD samples, as well as high levels of social avoidance, repetitive behaviour and language 
difficulties present in FXS+ASD, but not to the level of impairment noted in iASD. 
 
Thurman et al. (2015a) found boys with FXS demonstrated less impairment than ASD CA matched 
participants in reciprocal interaction behaviours.  FXS+ASD demonstrated less impairment than 
ASD in social smiling and showing and directing; and when matched for severity this was limited 
to social smiling.   FXS demonstrated significantly less gesture use than ASD CA matched 
participants.   Similarly, Wolfe et al. (2012) found those with FXS+ASD were significantly less 
severe than iASD on five ADOS measures of social behaviour.   These findings were contrary to 
Rogers et al. (2001). 
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Social Communication 
 
Thurman et al. (2015a) found that in verbal participants, social verbalisation and pronominal 
reversal was less impaired for FXS compared to CA matched, but not FXS+ASD.  Thurman et al. 
(2015b) evaluated the ability of boys with, FXS, iASD and TD to learn new words based on a 
social emotional cue, as an indicator of ability to understand social communication.  In the 
successful search condition, their findings indicated those with FXS are less impaired than those 
with ASD and not significantly different to TD children, consistent with findings of Wolff et al. 
(2012).  This study did not use an FXS+ASD control but did statistically control for ASD severity, 
following which there was no significant difference between the groups. In the unsuccessful search 
condition, it was the FXS group who demonstrated significantly lower performance than the TD 
and iASD groups (after controlling for ASD severity).  The differences between condition indicate 
the potential role of social avoidance in poor word learning.   
 
Further exploration of pragmatic language, undertaken by Martin et al. (2018), found both genders 
with FXS+ASD had profiles matching boys with iASD.  Boys with iASD initiated turns less often 
and were more non-responsive than other groups, whilst girls’ non-responsiveness was less 
favourable than boys within the FXS+ASD group. Boys with FXS+ASD and iASD used more 
non-contingent language than boys with FXS, DS and TD, providing support for a continuum 
model of impairment. Whereas girls with FXS+ASD were more non-contingent than girls across 
all other groups, a difference that could be a specific BP for girls with FXS+ASD.   
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Roberts et al., (2018) utilised an adolescent and young adult male sample to study the behavioural 
and biological aspects of social anxiety in FXS, FXS+ASD and ASD.  The FXS group had initial 
social avoidance and FXS+ASD group had prolonged social avoidance, in line with ASD BP.  
Salivary cortisol appeared to be a marker of general disrupted arousal rather than specific indicator 
of social avoidance. However, limitations included a smaller sample size of ASD, not matched on 
nonverbal IQ or expressive language. The study highlights the complexity in measuring cortisol, 
anxiety and ASD traits in FXS and conclusions echo existing literature (e.g. Hardiman & Bratt. 
2016; Corbett et al., 2006; Spratt et al., 2012) that the relationship remains unclear.  
 
Thurman et al. (2014) examined the profile of anxiety in boys with FXS compared to iASD. They 
reported a positive association between social avoidance and general anxiety in FXS, more so than 
in iASD when controlled for CA, nonverbal cognitive ability and or ASD symptoms. Conclusions 
from this study highlight that anxiety is a significant contributory factor in functioning for boys 
with FXS, a potential key difference in the development of phenotypes of FXS and iASD which 
would provide validity for the need for different target intervention between the two. Limitations 
included assessing psychiatric symptoms through parental report and narrowed focus on boys. 
 
Restricted Interests/ Repetitive behaviour 
 
Boys with FXS and FXS+ASD demonstrated significantly lower restrictive and repetitive 
behaviour severity scores than boys with iASD.  (Kau et al., 2004; Lee et al., 2016).  Kau et al 
(2004) established iASD showed greater impairment in restricted and repetitive behaviours at a 
later time point.  Kau et al (2004) conclude that stereotypical behaviours (and communication 
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impairment) contribute more to the diagnosis of ASD in the FXS+ASD group. These results fit 
with the finding reported by Rogers et al (2001). They concluded that there is a distinctive SBP 
sub-phenotype in boys with FXS which may share pathophysiological mechanisms reported in 
iASD. 
 
Similarly, Thurman et al (2015a) concluded that in restricted or repetitive interest items FXS were 
significantly less impaired than iASD for unusual preoccupation and compulsions and rituals than 
CA and FXS+ASD matched groups.  Complex mannerisms were observed to be more impaired in 
boys with FXS than severity-matched group.   
 
Rogers et al. (2001) found an FXS group presented with higher ASD traits than a DD group of 
young children (21-48 months).  The iASD and FXS+ASD did not differ significantly on any of 
the variables.  The FXS-O and iASD group differed significantly on all but the Repetitive 
behaviours and stereotyped patterns scale of the ADI-R.  Within the FXS cohort two sub-groups 
emerged: FXS group (virtually identical performance to DD group) and an FXS+ASD group 
(virtually identical performance to iASD group). Consistent with the literature (e.g. Hall et al., 
2010; Kau et al., 2004; Smith et al., 2012), Rogers et al. (2001) support the perspective that 
children with FXS+ASD present with an extension of the FXS BP rather than a distinct condition 
that sets them apart from children with FXS-O.  They attempt to explain this by the young 
chronological and developmental age of the sample and the lack of a developmental trajectory 
methodology.   
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Wolff et al. (2012) used a similar aged sample (3-5 years) but found significantly less compulsive 
or ritualistic behaviour in boys with FXS+ASD than boys with iASD; contrary to McDuffie et al 
(2015) who used older children and found FXS were significantly more impaired than iASD in 
compulsive and ritualistic items of this ADI-R scale.    
 
IQ & Adaptive Behaviour 
 
There is already a consensus regarding the high frequency of ID in males and less frequent 
presence in females (e.g. Hagerman et al., 2009; Gallagher & Hallahan, 2012; Crawford et al., 
2015).  Hall et al. (2010) used a regression model to show IQ was significantly negatively 
associated with SCQ score in both girls and boys with FXS (Hall et al., 2010).   
 
Increased severity in FXS and reduced severity in FXS+ASD over time (despite stability in 
diagnosis) means differentiation between the two presentations was harder. FXS+ASD IQ scores 
were stable over time, but FXS verbal IQ decreased over time (Hernandez et al., 2009).   The latter 
outcome is a consequence of the decline in VIQ over time, relative to TD children (Hernandez et 
al., 2009). However, raw scores of VIQ are not reported.   
 
Kau et al. (2004) suggest that FXS+ASD present increased problematic behaviour, reduced 
cognitive ability and adaptive behaviour. Specifically, the FXS+ASD had lower IQ scores, 
displayed greater impairment in aberrant and problematic behaviour, particularly regarding social 
avoidance/withdrawal with lower age equivalent scores of adaptive behaviours. 
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Lee et al. (2016) found over time girls demonstrated reduced rates of ASD symptoms relative to 
boys but not when controlling for structural language and mental age.  They indicated that 
pragmatic language ability was a significant variable influencing ASD assessment outcome in 
individuals with FXS.   
 
Methodology observations 
 
Hernandez et al. (2009), Lee et al. (2016) and Thurman et al. (2015a) all utilised a longitudinal 
methodology.  These studies highlight the value of a developmental perspective in FXS and 
limitations of using a single time point for comorbid ASD assessment and diagnosis in clinical 
practice. However, the reliance on the ADI-R by Hernandez et al. (2009) as the sole measure of 
ASD is a limitation, due to the disadvantages of sole reliance on parental report.  Although the 
other studies utilised the ADOS in addition to the ADI-R, there is evidence of a lack of consensus 
between the measures (e.g. Hall et al., 2010; Klusek et al., 2014) which is not addressed.  In 
addition, Lee et al. (2016) assessed the majority of participants at time 2 using ADOS module 3, 
therefore diagnosis was more reliant on expressive language, thus limiting generalisability to 
verbal children. 
 
Hall et al. (2010), Kau et al. (2004), Klusek et al. (2014) and McDuffie et al (2015) used samples 
with a chronological age mean that was older than the early infant studies (e.g. Rogers et al., 2001; 
Wolff et al., 2012), although Hall et al. (2010) ranged to young adulthood (5-25 years).  Hall et al. 
(2010) and Klusek et al. (2014) describe similar percentages of FXS+ASD.  Both studies highlight 
limitations with parental and observational measures used.  Wolfe et al (2012) acknowledge that 
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their use of the ADOS may have led to rater error and limited sample selection.  However, only 
approximately half of the Hall et al. (2010) sample were assessed using ADI-R and ADOS, which 
limits the findings due to differences in diagnostic outcomes for these measures indicated by 
Klusek et al. (2014).   
 
The findings of Thurman et al (2015a) are limited by the nature of the ADI-R reliance on parental 
report and lack of supported from a practitioner administered observational measure.  They are 
also not generalisable to participants with IQ greater than 85.  Thurman et al. (2015 b) had similar 
limitations to that of Thurman et al. (2015a); where individuals with ASD with higher IQ (>85) 
were excluded, as such, the findings are not representative of boys with iASD. Sample size was 
also fairly low for requirements of a regression model and the ADOS was not administered to the 
TD group to rule out any undiagnosed children, so effecting certainty that the differences across 
groups were due to presentation.  
 
The majority of studies utilised solely male participants; however, gender differences were 
considered by Hall et al. (2010), Klusek et al. (2014) and Martin et al. (2018) who consistently 
reported ASD as more prevalent in boys than in girls with FXS (Hall et al., 2010, Lee et al., 2016, 
Klusek et al., 2014).  This is also supported in the wider literature (e.g. Clifford et al., 2007); 
although Klusek et al (2014) reported that in clinical practice only 25% of both genders received 
a diagnosis which may reflect under diagnosis.   
 
The generalisation of findings by Hall et al. (2010), Klusek et al. (2014) and Lee et al. (2016) are 
limited for girls to those with expressive language.   The developmental trajectory implications 
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indicated by Hernandez et al. (2009), Lee et al. (2016), Thurman et al. (2015a) and Hall et al. 
(2010) suggest that findings should be interpreted with caution due to the difference between the 
mean and control sample ages.  Martin et al. (2018) had similar limitations having been unable to 
recruit non-verbal mental aged matched participants, instead using statistical analysis.  The latter 
study acknowledges that the examiner-child interactions does not portray an accurate assessment 
of ability in real-life situations, impacting on generalisability. Limitations of Kau et al (2004) 
include that the iASD group were significantly older than that of the FXS+ASD group, which 
considering the developmental trajectory of FXS+ASD, highlighted previously, is key.  The FXS 
group were significantly more impaired on IQ scores than the DLD group. 
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Discussion. 
 
This systematic review examined N=13 papers of good methodological quality that reported on 
ASD traits in children and young people with FXS.  The findings of these do not provide evidence 
that ASD traits in FXS represent a categorical distinct disorder within FXS that would achieve 
status within the DSM-V or ICD-10 as FXS+ASD as opposed to a comorbid ASD diagnosis.  
Instead, there appears to be a consensus that the distinction between ASD and FXS BP is based on 
variation in impairment.  The current review considers a continuum model helpful for synthesising 
these findings to distinguish the direction of impairment on different BPs underpinning FXS, 
FXS+ASD and ASD; as well as a trajectory model to explain the development of BP over time, 
illustrating a similar developmental trajectory for FXS and FXS+ASD over time, with 
symptomology severity or impairment increasing with chronological age; whereas trajectory for 
ASD symptomology, although heterogeneous, is stable over time.    
Proposed provisional behavioural phenotype continuum of FXS, FXS+ASD, ASD: 
 
The papers reviewed provide varying amounts of evidence for the presence of a BP for FXS+ASD 
which differs from the BP for FXS and iASD.  Figure 2 displays an illustration of the comparative 
level of impairment associated with BP in individuals who present with FXS, FXS+ASD or ASD.  
The distinction between FXS, FXS+ASD and ASD appears best explained on a continuum, with 
impairment associated with BP differing comparatively between the three presentations.   A 
discussion of the evidence contributing to this illustration follows.   
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Figure 2: Behavioural phenotype demonstrated in FXS, FXS+ASD and iASD, with 
indication of the comparative direction of level of impairment where there is a consensus in 
the review 
 
Synthesis of study outcomes highlights the significant contribution of social interaction 
characteristics that contribute to the differentiation in the distinct characteristics of FXS, 
FXS+ASD and ASD (eg. Hall et al., 2010; Hermandez et al. 2009; Lee et al., 2016; Wolff et al., 
2012; Rogers et al., 2001).  Ultimately, there is a consensus that reciprocal social interaction 
characteristics are more impaired for ASD than FXS+ASD, which are more impaired than FXS.  
However, there is a disparity in the direction of impairment for BPs that make up social 
communication, highlighted by the social element of language development and the distinction 
between social anxiety (e.g. Kau et al. 2004; Klusek et al., 2014; Thurman et al. 2010) and social 
avoidance (e.g. Roberts et al., 2018; Hall et al. 2010).   
 
Social anxiety BP are significant in distinguishing between FXS, FXS+ASD and ASD, with the 
direction of impairment indicating FXS are more impaired than FXS+ASD who are more impaired 
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than ASD.  Consideration of the BPs associated with language acquisition were fundamental to 
understanding this finding, with emotional cuing indicating the impairment in social 
communication (e.g. Thurman et al. 2015a; Thurman et al. 2015b).  The difference in direction of 
impairment of social avoidance and social anxiety may be explained by the findings from cortisol 
studies that indicate disrupted arousal present in FXS, rather than pure social avoidance. Thus, 
suggesting a biological underpinning, regardless of social situation, which may be unresponsive 
to psychological or behavioural intervention.     
 
Stereotypical behaviour is a significant BP for those with FXS+ASD, who present with more 
impairment than FXS alone (e.g. Rogers, 2001; Thurman et al., 2010; Lee et al., 2016).  However, 
it appears to be a feature of the FXS BP that develops later on the developmental trajectory.  Its 
absence in younger children with FXS may be key to a diagnosis of ASD not being provided (Kau, 
2004).  Consequently, it is proposed as a key item to track over time, but with consideration of the 
confounding variable of ID due to the association of increased repetitive behaviour and ID.  
Impairment in adaptive behaviours appears to correlate with impairment in IQ, which is more 
impaired in FXS than FXS+ASD, than ASD (e.g. Hernandez et al., 2009; Kau et al. 2004; Klusek 
et al., 2014) 
 
Overall, synthesis of the reviewed studies suggests a developmental trajectory of impairment, 
indicating increased impairment over time for FXS (Rogers et al., 2001).  The trajectory model is 
presented visually in Figure 3. 
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Figure 3: Illustration of the proposed trajectory of severity of ASD traits displayed in the 
BP of FXS, FXS+ASD and iASD over time  
 
Review limitations  
 
Ultimately, this systematic review was limited by the nature of evidence that it reviewed.  Studies 
were limited to cross sectional and cohort studies, with 2 longitudinal studies.  The review did not 
include intervention studies and consequently no randomised controlled trials (RCTs) were 
included.  General limitations of the review included the heterogeneous nature of the studies; their 
participants; the BP being measured; their methodology; their assessment measures.  The diverse 
nature of the studies meant that although odds ratio (OR) or effect size (ES) was reported in some 
studies, it was only appropriate to conduct a review of the studies and their data analysis, rather 
than conduct a meta-analysis of their ORs.   
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In addition to the potential limitation of over-reliance on parental report for assessment, parents of 
children with FXS provide the additional potential disadvantage of presenting with associated BP 
or symptoms associated with the syndrome.  A significant limitation in the review studies is the 
weighting of male participants in studies, due to the associated lower IQ and increase prevalence 
of ID in males with FXS. Research into the BP of iASD traits in individuals with a diagnosis of 
FXS to pursue findings highlighted by Hall et al. (2010) regression analysis with regard to the role 
of IQ in ASD BP within FXS, would be more successful through analysis of female participants 
due to the reduced variability in cognitive ability.    
 
The review was limited to BP underlying FXS and ASD presentations; however, there is also 
significant comorbidity with FXS and ADHD, which warrants exploring and the overlap with 
some BP of ASD may provide further insight into understanding FXS.  As such, the review 
exclusion criteria also limited a much broader focus of potential underlying mechanisms involved 
in the development or cause of BP, with a narrower focus on the observable BP across FXS and 
iASD.  
Research implications 
 
This review has highlighted some testable hypotheses for future research, illustrated in Figure 3, 
including the following proposals: increase of repetitive and restrictive behaviour over time in 
FXS+ASD compared to FXS; increased impairment in reciprocal social interaction BP; and the 
specific pragmatic language deficits.  Future research needs to address the limitations of the current 
review and associated studies while attempting to utilise female participants, with a longitudinal 
focus and minimise the reliance on parental reports of behaviour.  A move towards longitudinal 
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studies is needed to test out the trajectory hypothesis arrived at by this review.  Research examining 
the outcomes of interventions for symptoms present across FXS, FXS+ASD and iASD with a 
focus on outcomes for underlying biological symptoms, such as the role of cortisol, may be key to 
providing further distinction. 
Clinical implications and conclusions 
 
Rational for this review emerged following debate regarding the distinction between FXS and 
FXS+ASD and whether the latter was a distinct disorder.  The current review has considered 
evidence for BPs to clarify this and proposed a trajectory model, as well as indicated direction of 
impairments for the distinctive BPs of FXS and FXS+ASD.  As a consequence, the term FXS+ is 
proposed as a descriptor for FXS+ASD, with the rationale that it highlights FXS+ASD as 
demonstrating more significant ASD traits and associated impairment.  This hypothesis leads to 
the question of whether FXS and FXS+ are genetically distinct, with alleles present in the latter 
group that determine the development of ASD characteristics.  
 
There is an undeniable under-diagnosis in clinical practice of FXS+ (Klusek et al., 2014) and BP 
that mirror ASD can go undiagnosed. The status quo reinforces demand for clinical services to 
accept cases based on symptomatology, need and QoL as opposed to diagnosis.  While clinical 
service provision continues to be organised based on the categorical system of diagnosis supported 
by DSM-IV & ICD-10, FXS may not receive a service that could improve QoL.  The current 
review highlighted the significance of impairment in reciprocal social interaction, restrictive and 
repetitive behaviours, and social language difficulties for individuals with FXS+.  Specifically, 
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indicating the biological underpinning of social avoidance in FXS with indications for the clinical 
management of the BP.   
 
The developmental trajectory of FXS appears the most significant factor for consideration in 
clinical practice and future research as this review concludes the behavioural phenotype of FXS 
changes significantly with CA in contrast to iASD BP, which on the whole remains fairly 
consistent throughout development.  Of particular relevance is the contribution of reciprocal social 
interaction, which presents across developmental stages and restrictive and repetitive behaviours 
that increase in impairment over time.  Current service provision and capacity makes diagnosis for 
ASD likely to result from assessment at one time point in clinical practice, this may exclude for 
children with FXS from relevant services given the trajectory of FXS+ symptomology. 
 
It is likely that clinical guidelines documenting an appropriate diagnostic pathway and associated 
interventions for FXS+ would increase the percentage of diagnoses and subsequent relevant 
service access for this group.  Considering the high prevalence of ASD traits, ID and psychiatric 
symptoms in individuals with FXS, clinical guidelines targeting these presentations would benefit 
from providing reference to people with FXS and associated assessment and intervention 
guidelines.  However, the development of such interventions relies on further clarification of the 
evidence base within the literature on FXS.  
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Abstract 
 
Background: Prevalence of Autism Spectrum Disorder (ASD) traits in individuals with Fragile X 
Syndrome (FXS) is significant, with boys displaying more severely impaired behavioural 
phenotypes (BP) than girls and a higher incidence of intellectual disability (ID).  Distinguishing 
differences in the BP of girls and boys may provide insight into the relationship between FXS and 
ASD.  
 
Methods:  Parents of children with FXS (n=48) completed measures via an online platform 
advertised by the FXS society.  Data was collected for 39 boys and 9 girls with FXS using the 
Social Responsiveness Scale – second edition; the Repetitive Behavioural Questionnaire 2 and the 
Wessex Questionnaire. Statistical analysis using Mann-Whitney U test, Kruskal-Wallis H test and 
partial correlation analysis was conducted. 
 
Results: Severity of ASD traits in girls compared to boys with FXS did not differ significantly; 
the BP of FXS-O was significantly different to FXS+ASD; and ASD traits were not correlated 
with ID, irrespective of gender.   
 
Discussion: The incidence of ASD traits in FXS increased with age, supporting a trajectory model 
for development of ASD BPs.  The lack of distinction in ASD traits between boys and girls may 
reflect the BPs assessed by the measures, with psychiatric, language and executive functioning 
more difficult to assess via parental report measures. Limitations include the lack of clinician 
administered behavioural observational measures or assessment. 
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Introduction 
 
Genetic testing has enabled accurate diagnosis of Fragile X Syndrome (FXS), which affects 
approximately 1 in 4,000 males and 1 in 6,000 females (Boyle and Kaufmann, 2010). FXS has low 
homogenous behavioural properties, often perplexed by a range of Autism spectrum Disorder 
(ASD) qualities; as well as variable presence of phenotypes including attention deficits, 
hyperactivity/impulsivity, hyperarousal, anxiety and self-injurious behaviour (Boyle & Kaufmann, 
2010). Cognitive impairment is common, with FXS being the most commonly known genetic 
cause of intellectual disability (ID; Crawford, Acuña, & Sherman, 2001).  
 
FXS results from a cytosine-guanine-guanine (CGG) expansion on the X chromosome (Xq27.3), 
creating a direct correlation in the number of CGG repeats in the sequence and the severity of the 
phenotype in terms of physique, intellect and behaviour. The expansion typically leads to a 
decrease or absence of the fragile X mental retardation protein (FMRP), which is the protein 
produced by the FMR1 gene. Pre-mutation individuals or carriers have expansions in the region 
of 60 – 200 repeats, which do not significantly affect the transcription of FMRP; whereas 
expansions above 200 CGG repeats lead to full mutation (O’Brien, 2006).  
 
In contrast, the cause of ASD is largely idiopathic.  An exception being FXS, accounting for 
approximately 5% of cases, which is the most common genetic cause of ASD (Budimirovic and 
Kaufmann, 2011). With prevalence rates estimated at 1 in 100 UK (Baird et al., 2006) and 1 to 68 
in the USA (Baio, 2014), diagnosis of idiopathic ASD (iASD) is not as specific as FXS.  Diagnosis 
of iASD has historically been based on the presence, observation and/or report of behavioural 
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criteria, which include difficulty in; reciprocal social interaction (RI); and the presence of 
restrictive and repetitive stereotyped behaviours (RRB; American Psychiatric Association; APA, 
2013).   
 
In the UK, the diagnosis of iASD is made using the Diagnostic Statistics Manual (DSM-V; APA, 
2013) or International Classification of Diseases version 10 (ICD10; World Health Organization, 
1992) criteria.  Gold standard assessment requires the use of standardised measures that include; 
the Autism Diagnostic Interview – Revised (ADI-R; Lord et al. 1994); the Autism Diagnosis 
Observation Schedule (ADOS; Lord et al., 1989; Lord et al, 2000); or the Diagnostic Instrument 
for Social and Communication Disorders (DISCO; Wing, Leekam, Libby, Gould, & Larcombe, 
2002). The requirements for diagnosis outlined in the DSM-V and the psychometric properties of 
the ADOS and ADI-R, which were not specifically designed, normed or calibrated for FXS may 
lack specificity and consistency in diagnosing syndrome variances.  
 
Prevalence rates of FXS individuals proposed to have comorbid ASD fluctuate between 21 to 51% 
(Moss & Howlin, 2009), 22 to 33% (Zafeiriou, Ververi, Dafoulis, Kalyva, & Vargiami, 2013) and 
30% (male only), with mixed sex rates at 22% (Richards, Jones, Groves, Moss, & Oliver, 2015). 
In a sample of 63 boys with FXS (aged 2-19), 68% met the criteria for ASD using the ADOS, 
ADI-R or DSM-IV.  However, only 24% met the diagnostic criteria with a consensus on all three 
(Harris et al., 2008).  This may indicate the inconsistencies of applying dichotomously defined 
diagnoses, to behaviours and symptoms that vary throughout a developmental trajectory (Hall et 
al., 2010). Although the phenotypical behaviour observed in FXS and iASD are similar (Hagerman 
et al. 1986), recent literature proposes that FXS presents its own unique behavioural phenotype 
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(BP; BPs for plural) that differs from that observed in iASD (Clifford et al. 2007; Harris et al. 
2008; Moss & Howlin, 2009; McDuffie, Thurman, Hagerman, & Abbeduto, 2015).  
 
The aetiology of ASD continues to be explored: Feinstein and Reiss (1998) proposed that ASD 
symptomology in FXS was underpinned by a specific genetic allele; while Baron-Cohen, 
Nikmeyer and Belmonte (2005) and Aueyung et al. (2009) are exploring the role of foetal 
testosterone and the links to autism traits in males and females. Advances in neuroimaging indicate 
structural and functional brain differences between individuals with FXS and individuals with 
iASD.  These differences potentially arise from different neural substrates and reflect different 
underlying psychological impairments (Gallagher and Hallahan, 2012).  
 
Early infant studies (Rogers et al, 2001; Wolff et al, 2017) and studies using older children (Hall 
et al., 2010, Kau et al., 2004, Klusek et al., 2014; McDuffie et al., 2015) support the findings of 
longitudinal studies (Hernandez et al., 2009; Lee et al. 2016) that the trajectory of FXS-O, 
FXS+ASD and iASD are different. Thomas, Daffin & Hare (in submission) propose a trajectory 
model of FXS and FXS+ with symptoms of ASD in FXS increasing with age, which differs from 
iASD BP which is generally stable over time. Specifically, restricted and repetitive interests appear 
to emerge at a later chronological age in FXS (Lee et al. 2016), which may contribute to under 
diagnosis of ASD in younger children with FXS. Hernandez et al. (2009) highlight the contribution 
of peer relationships, adaptability in socialisation, and social withdrawal, to ASD diagnosis. They 
illustrate that increased problems with Reciprocal Social Interaction differentiate FXS from 
FXS+ASD, the latter experiencing elevated difficulties.     Hall, Lightbody, Hirt, Rezvani, & Reiss 
(2010), found a positive correlation between ASD traits and IQ using the Social Communication 
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Questionnaire (SCQ), supporting findings that ASD traits increased with level of intellectual 
impairment (Hessl et al., 2009). 
Gender differences 
 
Females with FXS tend to have reduced levels of FMRP, but not a complete absence.  This 
typically results in a less severe physical and less cognitively impaired BP, although in some cases 
presentation can be equivocal to males (Gallagher & Hallahan. 2012). Cognitive deficits are less 
common (approximately 25% have ID, (IQ < 70) amongst females with FXS (Hagerman et al., 
1992) but when an ID is present it tends to effect executive functioning (Riddle et al., 1997) with 
girls presenting with significantly more executive functioning problems than boys (Rinehart, 
Cornish & Tonge, 2010; Klusek, Martin, & Losh, 2014). 
 
Research into girls with FXS is not as substantive as that with boys, but it does highlight that a 
substantial number of girls present with symptoms related to inattention that cannot be explained 
solely by low cognitive ability (Mazzocco et al. 1998). Lee et al. (2016) concluded that girls 
displayed lower levels of ASD symptoms, but not when structural language and mental age are 
controlled for.  Social language skills with interactions with others, such as eye contact, facial 
expressions and verbal communication were a significant variable influencing ASD assessment 
outcome in FXS (Lee et al., 2016). In social communication presentation, gender differences were 
noted by Martin et al. (2018) with girls being more non-responsive than boys within the FXS+ASD 
group. Boys with FXS+ASD used more non-contingent language than boys with FXS only and 
typically developing children but not boys with iASD only. Girls with FXS+ASD were more non-
contingent than girls across all other groups.   
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Gender differences in psychiatric presentation are noted by Rinehart et al. (2010), who highlight 
that post puberty females are more likely to experience mental health problems and consequently 
require appropriate psychiatric and psychological psychoeducation and assessment regarding this.  
Psychoeducation is recommended as the initial treatment intervention for children and families 
with neurodevelopmental disorders. Given that the information provided is predominantly based 
on studies with male participants (Rhinehart et al., 2010) the validity and generalisability of the 
psycho-education for girls with FXS must be questioned.    
 
Ranging between 50 to 77% of females will present with a BP of psychological difficulties 
associated with depression (Roberts et al., 2009) as well as observable behaviours relating to 
specific phobias, social anxiety, self-injurious behaviour, impulsivity, shyness, poor eye contact, 
hyperactivity and inappropriate affect (Reiss, Hagerman, Vinogradov, Abrams & King, 1988; 
Hessl et al., 2008). Similar to these findings, Hull & Hagerman (1993) compared females with 
FXS to their female siblings without FXS and characterised specific behavioural phenotypes that 
presented in the siblings with FXS. These included: attention difficulties and hyperactivity; 
impulsivity; poor eye contact; hand flapping and biting.  Furthermore, high rates of emotional 
regulation difficulties, depression, social anxiety and agoraphobia have also been reported in 
female carriers of FXS (Hull & Hagerman, 1993; Franke et al., 1998; Hessl et al., 2008; Roberts 
et al., 2009; Bourgeois et al., 2009).  
 
ASD traits appear more prevalent in boys than in girls with FXS (Clifford et al., 2007; Hall et al., 
2010, Lee et al., 2016, Klusek et al., 2014). Klusek et al (2014) noted that in clinical practice this 
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fails to translate to a diagnosis, with only 25% of both genders receiving a diagnosis. Equally 
Bailey et al (1993) demonstrated that 5% of 40 girls with a diagnosis of ASD screened positive for 
FXS without prior knowledge that they may have the syndrome. Highlighting the potential for 
misdiagnosis across the two categories.  
 
Research question 
 
Research in to BPs that exist across disorders such as FXS and iASD could prove significant in 
elucidating gene behaviour relationships (Hall et al., 2010; Martin, Bush, Klusek, Patel, & Losh, 
2018). More research is required to fully delineate the BP of ASD traits present in FXS and detailed 
characterisation of shared phenotypes is necessary to understand why not all ASD BPs present 
similarly across individuals with FXS (Lee et al., 2016).   Additional research is required to explore 
the proposed trajectory model of FXS and FXS+ (Thomas, Daffin & Hare; in submission), which 
hypotheses that FXS+ASD is not a distinct phenotype from FXS-O but that symptoms of ASD in 
FXS increase with age.  Specifically, research into females with FXS is limited in comparison to 
that of males. Comparison of males and females with a diagnosis of FXS is hypothesised to aid 
greater understanding of the range of BP of ASD traits present across individuals with FXS. This 
has important implications for the development of specific evidence-based interventions and 
appropriate support for individuals and their families. 
 
The principle aim of the current study is to examine differences in the BP of boys and girls with 
FXS. Comparison of those who have a diagnosis of FXS only (FXS-O) will be compared to those 
participants who have a comorbid diagnosis of FXS and ASD (FXS+ASD).  
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Hypothesis 1: The severity of ASD traits in girls with FXS will be significantly lower from that 
observed in boys with FXS 
 
Hypothesis 2: The behavioural phenotype of participants with FXS-O will not differ significantly 
from the behavioural phenotype of those with comorbid diagnosis of FXS+ASD.  
 
Hypothesis 3: Both social communication difficulties and restrictive and repetitive behaviours will 
be positively associated with intellectual disability irrespective of gender.   
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Method 
 
This study was undertaken in collaboration with UK Fragile X Society. It was the second in a 
series of studies of FXS in this collaboration.  Consequently, some methods and design were 
matched with the previous study in order to pool data to reduce the demand on participating 
families of children with FXS.  
 
Participants 
 
Participants were recruited via the FXS Society’s database and its associated social media outlets 
such as Facebook and Twitter. CEREBRA (Welsh charity for families of children with brain 
injuries) were also provided information on the study and invited to share with their members to 
participate. A primary inclusion criterion was being a parent of a child or children, under the age 
of 16 years, with a genetically confirmed diagnosis of FXS. Participant data from the first of the 
studies in this series (Daffin, Thomas, Hardiman & Hare; in submission) and additional data from 
participants in this study were combined.  In total 48 participants completed the study. All 48 were 
recruited from FXS Society. No participants were recruited from CEREBRA. Completed data was 
returned on 39 boys and 9 girls with FXS. There was a relatively high rate of partial responders 
(n=43), whose data could not be analysed. Table 1 provides gender, age range and diagnosis 
information for children represented in the data.  
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Table 1: Gender, age range and diagnosis category of children represented in the data. 
CLINICAL GROUP 
FXS+ASD (N=23) FXS-O (N=25) 
GIRLS (N=3)  BOYS (N=20) GIRLS (N=6) BOYS (N=19) 
0-5 6-10  11-15  0-5  6-10  11-15  0-5  6-10 11-15  0-5  6-10 11-15  
N=0 N=2 N=1 N=1 N=9 N=10 N=0 N=2 N=4 N=9 N=6 N=4 
Key: FXS+ASD group contains participants with dual diagnosis of ASD and FXS. FXS-O group contains 
participants with FXS diagnosis only.  Diagnosis for FXS was based on the affirmative parental response 
for the question “Does your child have genetic testing confirmation of FXS?”. Diagnosis for ASD was 
based on the affirmative parental response for the question “Does your child have a diagnosis of an Autism 
Spectrum Condition?”. 0-5, 6-10, 11-15 = age groups in years. N = number of participants in each category. 
 
Measures 
 
Measures completed by participants included the; Social Responsiveness Scale – second edition 
(SRS-2; Constantino and Gruber, 2012); the Repetitive Behavioural Questionnaire 2 (RBQ-2; 
Leekam et al., 2007) and the Wessex Questionnaire (Kushlick, Blunden, & Cox, 1973).  Table 2 
documents the subscales comprised within each measure. 
 
Table 2. Subscales contained with the SRS-2, RBQ-2 and Wessex Questionnaire 
SRS-2 subscales RBQ-2 subscales  Wessex subscales 
 
Social awareness 
 
Repetitive Motor Movements.  
	Continence	
 
Social cognition 
 
Rigidity/Adherence to Routine 
 
	Mobility 
 
Social communication 
 
Preoccupation with Restricted 
Patterns of Interest 
 
	Self-help	skills 
Social motivation Unusual	Sensory	Interest	
 
Speech and literacy 
 
Restricted interests & repetitive 
behaviour 
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The SRS-2 is 65-item rating scale measuring deficits in social behaviour. The School-Age form 
takes approximately 15 minutes to complete by a parent or teacher who knows the child. It 
measures the severity of ASD symptoms presented by the child in their natural environment. It 
was developed for use with children 4 – 18 years of age and focussed on the child’s level of social 
impairments. It assesses social awareness, social anxiety/avoidance, social information processing, 
capacity for reciprocal social communication, and autistic preoccupations and traits. Items are 
scored on a 4-point scale, ranging from not true = 1, sometimes true = 2, often true = 3, to almost 
always true = 4. Scoring the SRS-2 can be done by hand or computer programme with results 
reported as T-scores (M = 50, SD = 10) for five treatment subscales: receptive, cognitive, 
expressive, motivational and preoccupation. When interpreting the SRS-2, total score is the most 
reliable measure of social deficits related to ASD. T-scores of 76 or higher are considered severe, 
suggesting that an individual has clinically significant deficits in social functioning; T-scores 
between 66 and 75 are considered moderate and indicative of some clinically significant social 
deficits; T-scores between 60 and 65 reflect mild difficulties in social behaviour; with T-scores of 
<60 reflecting that an individual probably does not have social difficulties indicative of an ASD 
diagnosis.  
 
The SRS-2 provides a total score and subscale scores; the total score is the most reliable indicator 
of social deficits related to ASD. The authors of the measure have reported strong internal 
consistency across gender, age and clinical subgroups within the clinical sample. The authors 
clinical sample yielded a total reliability coefficient of .95, evidencing strong consistency across 
items. The authors Predictive validity analysis of their sample resulted in a sensitivity value of .92, 
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suggesting that the scale identifies 92% of individuals accurately, and specificity value of .92, 
indicating that 92% of individuals without ASD will not be identified by the SRS-2 as having the 
disorder. Thus, the SRS-2 does well in identifying those with and without characteristics of ASD. 
The authors described how the SRS-2 model aligns with the symptom criteria proposed for the 
DSM-5 (Constantino & Gruber, 2012). 
 
The RBQ-2 is a twenty item, four-factor measure developed to measure unusual sensory interests, 
repetitive motor movements, rigidity/adherence to routine and preoccupations with restricted 
patterns of interests, which closely resemble the repetitive behaviour subtypes outlined by the ICD-
10 (WHO, 1992). The RBQ-2 is directly derived from a standardised clinical interview tool, the 
DISCO (Wing et al., 2002) which has good inter-rater reliability and discriminant validity (Leekam 
et al. 2002; Nygren et al., 2009; Maljaars et al., 2012) as well as strong agreement with outputs 
from ADI-R (Nygren et al., 2009) and ADOS (Maljaars et al., 2012) which are validated and 
widely accepted clinical instruments. The RBQ-2 was developed using two geographical 
subsamples and reports good internal consistency (alpha = 0.85), inter-item validity, and across 
samples reliability and validity. The coefficient alpha statistics for each of the four sub-scales 
(repetitive movements alpha = 0.80; rigidity alpha = 0.75; preoccupations alpha = 0.72; and 
sensory interest alpha = 0.66) suggest acceptable internal consistency. Originally validated for use 
with 2-year-olds, the RBQ-2 has gained acceptance as an appropriate measure for use with children 
and adolescents with ASD with good internal consistency across the whole scale (a=.86) and for 
both RSMB (a=.79) and IS (a=.83; Lidstone et al. 2014). Satisfactory endorsement of items and 
good internal consistency support the construct validity of the RBQ-2 in children and adolescents 
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(Barrett et al., 2015). Due to similar findings across studies, inclusion for the target population for 
the current study was deemed appropriate.  
 
The RBQ-2 is categorised into four different factors which reflect different subtypes of restrictive 
and repetitive behaviours such as Repetitive Motor Movements and Unusual Sensory Activities 
(see Table 3). Ratings are based on recent behaviour (observed in the last month). A total score 
(mean score 1.00 to 3.00) is calculated by adding the points given for each item in the measure 
and dividing by the number of questions answered.   
 
Table 3. RBQ-2 sections, items and scoring response  
Factor Item Numbers Score and response 
   
Repetitive Motor 
Movements 
2,3,4,5, 6 (1) never/rarely (2) once/twice a day (3) 15+ a day 
 
Rigidity/Adherence 
to Routine 
 
13, 14, 15, 16, 
17,18, 19 
 
(1) never/rarely (2) Mild/occasional (3) Marked/notable  
 
 
Preoccupation with 
Restricted Patterns of 
Interest 
 
Unusual Sensory 
Interest 
 
7, 8, 10, 11, 12, 
17 
 
 
8, 9, 10, 18 
 
(1) never/rarely (2) Mild/occasional (3) Marked/notable 
 
 
 
(1) never/rarely (2) Mild/occasional (3) Marked/notable 
 
 
Additional question 20  (1) Range of different and flexible self-chosen activities  
(2) Some varied and flexible interests but commonly 
chooses the same activities  
(3) Almost always chooses from a restricted range of 
repetitive 
Key: RBQ-2: Repetitive Behavioural Questionnaire 2; item response scoring options. 
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The Wessex Questionnaire (Kushlick et al., 1973) is used to assess several dimensions of ability 
in children and adults with ID. Comprised of five subscales, with a total of 15 items: continence 
(4 items); self-help skills (3 items); mobility (2 items); speech (1 items); literacy (3 items); vision 
and hearing (2 items);  Items are scored on a scale from 1 to 3, higher scores indicating a greater 
level of ability. It has good efficacy for use in large scale questionnaire studies with good inter-
rater reliability at both sub-scale and item level for adults and children (Richards, Oliver, Nelson, 
& Moss, 2012). A score of between 5 and 9 can be indicative of moderate to severe ID (Bell et al., 
2018). 
 
An online data collection platform was developed through Qualtrics (see appendix D) to providing 
a single point of access to these measures.  Demographical and questions exploring health and 
support needs, based on work by Bromley, Hare, Davison and Emerson (2004), were additional 
items added to platform. Paper copies of the questionnaires were available on request. The online 
link was distributed via the Fragile X society and available for twelve weeks. Participants received: 
an information sheet outlining the research and its aims (Appendix E); information outlining access 
to appropriate support and guidance available from the FXS society should any distress arise 
(Appendix F); and a consent form for their data to be included in the study (Appendix G).    
 
Ethics  
 
The proposed project received ethical approval to the Cardiff University School of Psychology 
Research (Appendix H) and also approved by the Fragile X Society (FXS-UK) research board. 
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Results 
 
Data Analysis Plan  
 
Descriptive statistics were calculated to establish the means, standard deviation and ranges of all 
measures.  When assessed for normality through analysis of histograms, box plots and formal tests 
of normality (Kolmogorov-Smirnov), significant skewness and kurtosis were apparent in the 
distribution for several key variables.   Due to the unequal sample sizes and assumptions of 
normality not being met, as assessed by the Kolmogorov-Smirnov tests (p<.05), non-parametric 
analysis was recommended (Tabachnick & Fidell, 2014). 
 
Kruskal-Wallis H tests and Mann-Whitney U tests were employed to test for between-group 
differences on SRS-2 and RBQ scores between gender and clinical groups. For hypothesis two, 
participants were put into 1 of 4 groups relating to Gender (Male / Female) by diagnosis (FXS-O 
/ FXS+ASD). This led to the creation of four groups; Male FXS+ASD, Female FXS+ASD, Male 
FXS and Female FXS. Finally, hypothesis testing involved exploring associations between IQ and 
ASD symptomology using Spearman’s Rank Order Correlations whilst controlling for gender. 
 
Descriptive Data 
 
The two samples (FXS and FXS+ASD) were matched group-wise on IQ scores. The male: female 
ratio was 19:6 in the FXS group and 20:3 in the FXS+ASD group. There were no significant group 
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differences for IQ scores (FXS group Mdn=36, IQR=6; FXS+ASD Mdn=35, IQR=6; U=265, z=-
.465, p=.642). 
 
Age and Diagnosis 
 
Regarding age groups of participants and clinical diagnosis, a chi-squared (c2) test of association 
revealed that there was a significant different between age groups of participants and associated 
diagnosis c2 = 7.27, p = .026.  As shown in Figure 1, there were significantly more 6-10 years olds 
with FXS+ASD and significantly more 11-15-year olds with FXS+ASD compared to FXS only. 
However, there was significantly more 0-5-year olds with FXS than FXS+ASD. 
 
Figure 1. Age groups of participants by Diagnosis 
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Table 4 provides means, standard deviations and ranges of measures for all participants and 
participant groups. Between-group differences on all measures are presented using Mann-Whitney 
U tests.  
 
Of note, the FXS+ASD group showed significant higher scores (p<.008) on the SRS-2 Total score 
than the FXS-O group; there was also a between group significant difference (p=.001) on SRS-2 
motivation subscale; and a significant difference (p=.016) on the SRS-2 repetition subscale.  
 
On the RBQ-2, participants in the FXS+ASD group scored significantly higher than the 
participants in the FXS-O on the Preoccupation with Patterns subscale (p=.005) and the Rigidity 
/Adherence to routine (p=.003) subscale. No other significant differences between the FXS+ASD 
and FXS-O groups were found on the measures using Mann-Whitney U tests. 
 
 
Severity across groups 
 
According to severity ratings suggested for the SRS-2, 72% of the FXS group had severe levels of 
social difficulties.  In the FXS+ASD group, 95% of participants had severe levels of ASD 
symptomology.  This shows that the SRS is accurately measuring social difficulties integral to 
ASD. 
 
Z-scores were calculated to highlight the profiles for the RBQ-2, SRS-2, and Wessex subscales. 
Figure 2 shows the z-scores of the girls in the study plotted against the z-scores of the boys acting 
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as control in order to provide a visual representation of the contrast in gender scores for the 
subscales.  
 
 67 
Table 4. Descriptive statistics for all measures for sample (n=48) 
Key: mean, standard deviation SRS-2: Social Responsiveness Scale – second edition total and subscale; RBQ-2: Repetitive Behavioural 
Questionnaire 2 total and subscale. 
 
 
Measure 
(Subscales) 
Entire Sample (N = 48) 
Mean (SD) Range 
FXS+ASD (N =23) 
Mean (SD) Range 
FXS-O (N = 25) 
Mean (SD) Range 
U p-value 
SRS-2 Total 151.16 (20.74) 113-212 158.26 (17.35) 121-188 144.64 (21.78) 113-212 159.00 .008 
SRS-2 Motivation 27.29 (4.51) 17-38 28.30 (4.02) 20-38 23.48 (5.20) 17-38 115.00 < .001 
SRS-2 Communication 41.14 (5.95) 31-57 40.22 (5.1) 32-51 42 (6.63) 31-57 209.00 .104 
SRS-2 Cognition 28.41 (5.11) 18-42 27.96 (4.14) 19-35 28.84 (5.93) 18-42 233.00 .263 
SRS-2 Awareness 19.77 (3.37) 11-31 18.96 (2.79) 11-23 20.52 (3.73) 15-31 282.50 .917 
SRS-2 Repetition 34.54 (7.2) 16-51 36 (6.42) 23-46 33.2 (7.75) 16-51 171.50 .016 
RBQ-2 Total 1.86 (.55) 1.05-3.50 2.00 (.53)1.05-3.15 1.72 (.55)1.10-3.50 195.00 .056 
RBQ-2 Repetitive Motor Movements 1.88 (.69)1.00 – 3.80 1.96 (.64)1.00-3.20 1.82 (.74)1.00-3.80 235.00 .273 
RBQ-2 Preoccupation with Patterns 1.10 (.38).57-2.00 1.25 (.36).57-2.00 .95 (.34).57-1.86  151.50 .005 
RBQ-2 Unusual sensory interests 1.21 (.50) .75-2.25 1.30 (.61).75-2.25 1.13 (.38).75-2.00 263.00 .602 
RBQ-2 Rigidity /Adherence to routine 2.14 (.68)1.14-3.71 2.43 (.67)1.00-3.20 1.87 (.58)1.14-3.71 145.50 .003 
Wessex Total 34.58 (8.11) 21-51 35.34 (8.05) 21-51 33.88 (8.26) 21-47 265.00 .642 
Wessex Continence 9.04 (3.01) 4-12 9.34 (3.14) 4-12 8.76 (2.93) 4-12 260.50 .567 
Wessex Mobility 6.66 (2.43) 3-9 6.78 (2.61) 3-9 6.56 (2.31) 3-9 251.50 .441 
Wessex Self-Help 9.52 (3.33) 5-15 9.78 (3.52) 5-15 9.28 (3.2) 5-15 260.00 .566 
Wessex Speech 9.22 (3.34) 4-17 9.3 (3.28) 4-17 9.16 (3.46) 4-17 280.00 .876 
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Figure 2. Cognitive profiles of girls plotted against the profile of boys as control.  
 
 
 
 
 
The visual representation of Figure 2 adapted from Iqbal et al., (2009) highlights that girls have 
a higher cognitive ability, or reduced likelihood of an ID, than boys across the subscales on the 
Wessex measure. Girls in this sample show greater frequency of ASD traits across both SRS-
2 and RBQ-2 measures with z-scores highlighting greater frequency of restrictive and repetitive 
behaviours and social interaction difficulties. Although z-scores for the girls indicate a greater 
score on SRS-2 social motivation subscale, the boys although less motivated, perform better at 
social interaction.  
 
Inferential testing  
 
Hypothesis 1: The severity of ASD traits in girls with FXS will be significantly lower from that 
observed in boys with FXS.    
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Using Gender as the independent variable, SRS-2 and RBQ-2 total scores were examined using 
a Mann-Whitney U test. The analysis revealed there was no significant difference between 
male and female participants with FXS on total scores of SRS-2 symptoms (U = 172.00, z = -
.09, p = .92) and RBQ-2 (U = 136.50, z = 1.03, p = .80).    Subsequently, a series of Mann-
Whitney U tests were conducted using gender as the independent variable and subscales from 
the SRS-2 and RBQ-2.  However, no statistically significant differences occurred between 
gender and any of the subscales for RBQ-2 or SRS-2 (p > .05). 
 
Hypothesis 2: The behavioural phenotype of participants with FXS-O will not differ 
significantly from the behavioural phenotype of those with comorbid diagnosis of FXS+ASD.  
 
A Kruskal-Wallis H test was conducted which showed that there was no statistically significant 
difference in total SRS-2 scores between participants with FXS-O and FXS+ASD χ2(2) = 
2.469, p = .291.  A second Kruskal-Wallis H test also showed there was no statistically 
significant difference in total RBQ-2 scores between FXS-O and FXS+ASD χ2(2) = 3.394, p 
= .183. 
 
Hypothesis 3: Both social communication difficulties and restrictive and repetitive behaviours 
will be positively associated with intellectual disability irrespective of gender.   
 
Using partial correlation analysis controlling for gender indicated that there were no significant 
associations between measure of ID (as guided by the Wessex) and total symptoms of SRS-2 
(r. = .03, p = .81) and RBQ-2 (r. = .11, p = .43). The following figures display these non-
significant findings visually.  Figure 3 visually plots total scores on RBQ-2 scores and Wessex 
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scores. Figure 4 visually plots total SRS-2 symptoms and Wessex scores. Figure 5 and 6 plot 
relationship between Wessex and both SRS-2 and RBQ-2 scores across different age groups. 
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Figure 3. Relationship between Wessex score and RBQ-2 (N = 48)                      Figure 4. Relationship between Wessex score and SRS-2 
(N = 48) 
                        
Figure 5. Group scatter by Age Group on Wessex and SRS-2 scores     Figure 6. Group scatter by Age Group on Wessex and RBQ-2 Scores 
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Discussion. 
 
This paper considered three main hypotheses.  These are discussed with reference to statistically 
significant differences, trends and observations. The original hypotheses are considered in turn here 
after: 
 
 Hypothesis 1: The severity of ASD traits in girls with FXS will be significantly lower from that 
observed in boys with FXS;  
 
ASD traits in girls did not differ significantly from boys and consequently the hypothesis was not 
accepted.  Contrary to much of the literature, boys with FXS did not present significantly higher rates 
of ASD symptoms than girls with FXS in this study. Inspection of participants’ visual profiles of the 
RBQ-2 and SRS-2 subscales illustrated a tendency for a higher rate of ASD symptoms in girls, 
although these differences did not reach significance.  This supported Gallagher and Hallahan’s (2012) 
conclusion that ASD profiles across FXS gender can present with equal severity.  
 
Outcomes from the Wessex questionnaire suggest that this finding would be irrespective of ID.  Thus, 
agreeing with Mazzocco’s (1998) conclusion that symptoms related to ASD are not explained solely 
by low cognitive ability. 
 
Girls scored higher than the males on Wessex scores, indicating less likelihood of the presence of ID, 
as specified by Hagerman et al., (1992).  In addition, the inferential statistics and cognitive profiles do 
not indicate a correlation between ID, as inferred by the Wessex questionnaire, and ASD traits.  This 
finding indicated that ASD traits were not correlated with level of cognitive ability.  This is contrary 
to Hall et al. (2010) who found a positive correlation between IQ and the SCQ score for boys and girls.  
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Although Hall et al. (2010) used different measures; their finding indicates an association between IQ 
and symptomology, which is not found in the current study. The Wessex Questionnaire has good inter-
rater reliability at subscale and item level (Richard et al., 2012) and scores between 5 and 9 have been 
indicated to indicate moderate ID (Bell et al, 2018).  However, it does not provide an accurate 
indication of cognitive ability, which may explain the discrepancy with the comparison with Hall et 
al. (2010).  These findings must be taken with caution due to the methodology.   
   
Hypothesis 2: The behavioural phenotype of girls and boys with FXS-O will not differ significantly 
from the behavioural phenotype of those with comorbid diagnosis of FXS+ASD. 
 
There was no statistically significant difference in total SRS-2 scores between participants with FXS-
O and FXS+ASD, or total RBQ-2 scores between FXS-O and FXS+ASD.  Statistical analysis indicated 
no significant difference in the total scores on these measures; the former considered to provide the 
most valid indication of social deficits indicative of ASD and the latter directly derived from a 
standardised assessment tool for ASD.  Consequently, this provided evidence to accept the hypothesis.  
However, within the subscales making up these measures there were significant differences between 
FXS+ASD and FXS-O groups found in repetition; preoccupation with patterns; and rigidity and 
adherence to routine, which all reflect symptoms associated with repetitive and restrictive interests.  
The direction of significance indicated more impairment for individuals with FXS+ASD than FXS.  
With FXS+ASD presenting with impairment more akin to individuals with ASD, although the current 
study did not include an ASD group for comparison.  This pattern of increased impairment from FXS 
(least impaired) to FXS+ASD (most impaired) supports the direction of impairment concluded by 
Thomas, Daffin & Hare (in submission).  However, it should be noted that the low sample number in 
this study could affect the statistical significance of this outcome. In addition, although FXS+ASD 
were significantly more impaired, the FXS-O group still presented with the BP’s. There could be 
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numerous variables that contribute to the development and severity of presentation such as: parental 
management; support from services; and environmental factors.  
 
 
 
Hypothesis 3: Both social communication difficulties and restrictive and repetitive behaviours will be 
positively associated with intellectual disability irrespective of gender.  
 
 
Repetitive and restrictive interest symptoms have been highlighted to emerge along a trajectory in FXS 
(Lee et al. 2016), potentially contributing to the increase in ASD diagnosis in older children with FXS 
and emphasising a difference in the BPs of children with FXS compared to FXS+ASD.  The presence 
of these symptoms for participants with FXS+ASD in the current study may be accounted for by the 
higher number of participants within the older children age ranges with FXS+ASD.  Significant 
differences indicated between FXS+ASD and FXS-O groups on the total score for the SRS-2 indicate 
the potential for use of the measure as a screening tool to identify the presence of ASD traits in FXS.  
However, the use of this measure in this way would require the identification of a cut off score to 
indicate the different presentations.   
 
The difference between motivation measured by the SRS-2 and compared between FXS-O and 
FXS+ASD was also significant.  The direction of significance indicated higher scores on the 
motivation subscale for the FXS-O group compared to the FXS+ASD group, suggesting that the latter 
group lack motivation.  Although cause cannot be determined by the current study, it may be that 
FXS+ASD present with more psychiatric symptoms (Roberts et al. 2009; Rinehart et al. 2010), which 
contribute to the relative lack of motivation in this group. 
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Comparison of the total SRS-2 score across the FXS and FXS+ASD group demonstrated a significant 
difference in social behaviour difficulties was present, supporting the findings by Hernandez et al. 
(2009) for different BPs for FXS and FXS+ASD, with FXS+ASD experiencing significantly elevated 
difficulties.  However, the lack of a significant different between groups for all items individually also 
provides support for the presence of ASD traits within FXS that would not meet the criteria for 
diagnostic cut off (Lee et al. 2016). 
 
The descriptive statistics indicate a significant difference in diagnosis (FXS-O vs FXS+ASD) between 
age range groups provides support for the trajectory model of FXS+ proposed by Thomas, Daffin & 
Hare (in submission).  As well as support for findings from longitudinal studies (Hernandez et al., 
2009; Lee et al, 2016) that indicate the trajectory of FXS and FXS+ASD are different.  The finding 
that significantly more children aged 6-10 and 11-16 had a diagnosis of FXS+ASD, than children aged 
0-5, supports that symptoms of ASD in FXS develop along a trajectory with chronological age.  Aged 
0-5 children may not present significantly differently to FXS peers and thus not attract a diagnosis, but 
then go on to develop ASD traits and receive comorbid diagnosis (FXS+ASD).  The lack of a 
significant difference between FXS and FXS+ASD in these early years could provide support for 
hypothesis 2, but a developmental methodology would need to be utilised to further investigate this.   
An increase in RRB (Lee et al. 2016) and psychiatric symptoms such as social anxiety (Roberts et al. 
2009; Reiss et al. 1988; Hessl et al., 2008) in conjunction with chronological age may explain the 
additional percentage of FXS+ASD diagnoses in older children in the current study. 
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Limitations 
 
The findings are impacted upon by the small sample size and unequal distribution of age and sex. This 
is particularly so for testing hypothesis 1 which aimed to compare boys with girls. The female sample 
size was far below that of boys (n=9 against n=39 respectively). Although this maybe representative 
of the population of FXS and the noted difficulty of attracting FXS females to participate in research 
projects, the findings should be taken in light of this. As mentioned, it is intended for this data to be 
pooled with future research data which will hopefully improve the sample size and subsequent effect 
size. Although every effort was made to reduce the burden on the families of children with FXS, the 
study measures were time consuming taking on average 30 minutes to complete. This could explain 
the relatively high rate of partial responders, although this may also be indicative of content or design 
of the platform itself.  The online platform enabled access to an international audience, but recruitment 
of participants to the level that would provide acceptable power (Cohen, 1992) and effect size was not 
achieved.  Sixty participants, with equal allocation to groups for comparison, would have provided 
acceptable power.  Consequently, recommendations for future research would be to re-run the 
statistical analysis with data from additional participants to bring the numbers up to appropriate power.  
Many studies in FXS hold a male dominant focus, and although this study included both sexes in the 
study, the number of male participants was far greater than that of female participants (N=39; N=9, 
respectively). This may be representative of the reduced prevalence and symptom severity in the 
female population.  
 
The current study recruited participants within three different age ranges and statistical analysis 
considered age as a variable.  The limitations of a small sample size impacted on the scope of the 
current study to interpret findings across a developmental trajectory.  Future research utilising a 
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longitudinal methodology to review BPs would provide more insight into the developmental trajectory 
of FXS+ASD BPs.    
 
Limitations associated with parental report in this study include the retrospective nature of their report, 
and the lack of formal training in identification of symptoms that the study aimed to assess, affecting 
reliability.  Although the use of parental self-report measures is standard practice when assessing 
symptomology in children, best practice would be to substantiate these findings with direct behavioural 
observation by trained assessors.  Alternative methodologies could include video analysis of BP by 
analysis of home video recordings, as used by Baranek et al. (2005).  In addition, the self-selecting 
sample may provide a bias, with the potential for parents to have self-selected to participate as a result 
of factors such as: their contact with the FX Society meaning they were more informed, or felt more 
supported; or contrarily their contact with the FX Society indicated a perceived higher level of 
difficulty perhaps reflecting more severe impairment in their child.  
 
The findings of the study are limited by a lack of consideration of contextual information regarding 
the participants, including no information about additional comorbid developmental or psychiatric 
diagnoses, such as Attention Deficit Hyperactivity Disorder, anxiety or depression.  This is may be 
relevant considering the higher prevalence of comorbid diagnosis for psychiatric disorders for girls 
with FXS and the BP of associated symptoms (Roberts et al. 2009; Rinehart et al. 2010). 
 
The study asked for verbal confirmation of FXS and ASD diagnosis (if present) but did not require 
formal clarification of diagnosis.  This may have impacted on the reliability and validity of findings.  
However, as participants were registered with the FX Society and there were no material gains from 
participating, it was considered that they would be honest in their self-report.  The measures used in 
the study were assessing for ASD traits and formal diagnosis was not required.  Future research should 
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consider sourcing this information or confirming diagnosis as part of the research study.  The 
generalisability of findings is limited due to the age of the participants, with future research 
recommended to include young people up to 25 in line with the age of intake for education provision. 
   
Clinical and Research implications 
 
Ultimately, this study highlights similarities between gender for FXS+ASD presentation, with ASD 
traits not considered solely related to cognitive ability.  Clinical implications from the current study 
include highlighting that ID and ASD traits are not always positively correlated.  Within this participant 
group ASD traits were as prevalent in females as in males, irrespective of ID.  There was also support 
for the trajectory model of the development of ASD symptoms in FXS over time.  Clinical implications 
include the need to assess for ASD later in developmental trajectory if early assessment is not 
indicative of ASD.  Future research should expand on gender comparisons, with an additional focus 
on the impact of psychiatric symptoms associated with BP.  A longitudinal focus will provide more 
information about the trajectory of symptoms and inform clinical provision for this client group. 
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Paper 3. 
Critical and reflective evaluation. 
 
 
 
The focus of this section is to provide a considered critique and reflective evaluation on the work 
undertaken in the systematic review (paper 1) and the empirical research study (paper 2). Literature on 
the process of reflection highlights an anticipatory phase, where prior experiences inform future 
actions (Mann, Gordon & MacLeod, 2009).  Discussion will consider the process undertaking this 
work, with reference to Mann et al (2009) anticipatory phase of reflection; then consider the strengths 
and weaknesses of these papers in relation to the methodology and their future contribution towards 
research, clinical practice, and most importantly the FXS population, their families and carers. 
Reflections on personal and professional development will be integrated throughout the sections of the 
paper. 
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Personal context 
 
I travelled a somewhat unorthodox route to clinical training. My initial psychology degree was 
completed approximately 16 years before I commenced the journey into DClinPsy.  My professional 
background prior to clinical training was working in Specialist Child and Adolescent Mental Health 
Services as a DBT and CBT therapist. Within this role I developed a surf therapy programme for 
adolescents diagnosed with Autism Spectrum Disorder (ASD), now in its eighth year of running. It 
was a difficult decision to leave this role as I thoroughly enjoyed the clinical work, meeting some truly 
inspiring young people on the way. The experience that I gained clinically has been fundamental to 
my progress through the DClinPsy, the challenge was always going to be returning to the world of 
research and academia. Balancing family life and the demands of the DClinPsy has been difficult at 
times, but always rewarding. I have three wonderful children who will be very pleased to see me 
emerge from my office (an old wooden tool shed in the garden) upon completion of this thesis.  
 
As a reflective practitioner, I am familiar with iterative reflection (Schon, 1983) where my personal 
experience triggers exploration and learning.  The proposed research project gained my interest due to 
the ASD traits often reported in FXS. I had experience of working therapeutically with a young woman 
with FXS and a number of individuals with an ASD. These experiences heightened my interest in ASD 
and FXS+ASD, with the passion I still hold from working in Specialist CAMHS for 10 years 
undoubtedly influencing the developmental focus of the research.   
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Review of Paper 1: Systematic review 
 
 
Rationale for topic 
 
Genetic testing has enabled accurate diagnosis of FXS, however, FXS has low homogenous 
behavioural properties, often perplexed by a range of ASD traits/symptoms and/or cognitive 
impairment. In such cases it remains unclear if this is a result of co-morbid ASD or if there is a specific 
behavioural phenotype for individuals diagnosed with FXS. Individuals with idiopathic Autism 
Spectrum Disorder (iASD) and FXS+ASD will have greater access to specialist services implemented 
to meet the rising need of ASD. This is often to the exclusion of some FXS individuals who do not 
meet the criteria for comorbid ASD diagnosis based on the outcomes of assessment tools designed for 
the ASD population. This has clinical implications for families as exclusion from services where 
specialist intervention is available for psychological and behavioural symptoms, often relies on the 
comorbid presence of ASD.  
 
The project was undertaken in collaboration with the FXS society and is the second in a series with a 
focus on FXS. Following the general selection of FXS as the research area, and background reading 
to establish the current research interest and direction, phenotypic behaviour and its potential to 
contribute to the understanding of FXS for families and clinical practice was selected. I considered an 
area of extant research to systematically review which would complement and justify the direction of 
the empirical focus. The intended topic validated as a beneficial focus for their members by the FXS 
society’s research board. This process was certainly aided by a carer from the FXS society who helped 
me develop the information sheets for the families involved. 
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Search strategy   
 
The systematic review was conducted in line with the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses Statement (PRISMA) and checklist (Appendix I) to ensure a methodical 
and transparent process (Moher, Liberati, Tetzlaff, & Altman, 2009). The initial search strategy was 
Ovid MEDLINE (1946-) followed by PsychINFO (1806-) and Embase (1947-). These databases were 
initially searched for relevant articles in August 2018. Although the discovery of the FMRI gene was 
in 1991 (Verkerk et al., 1991), no cut-off date was enforced at this juncture due to suggestions in the 
literature in the 1960’s that mutations in genes on the X chromosome may be significant and termed 
marker X (Gallagher and Hallahan, 2012). A later applied exclusion criteria of articles pre-2000, 
highlights the insignificance of this initial consideration.  
 
 
Additional papers were discovered through references of other articles. This would suggest that 
although I conducted a thorough and systematic literature search, my search terms were not specific 
enough to capture all relevant articles in the area of interest in this first stage. However, a thorough 
review of the papers retrieved promoted further specificity reassuring that through the overall process, 
all relative articles were found for synthesis.  
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Inclusion and exclusion criteria 
 
An early challenge of this paper was the fairly limited knowledge of the complexities of FXS. The 
process of conducting a literature search was akin to not knowing what you don’t know, until you know. 
As papers were being selected and read, more knowledge was gained into the area of FXS and ASD; 
with levels of reflection occurring within this process in order to provide a transformative experience 
in learning (Moon, 1999). My interest and direction often widened to the risk of being too broad with 
what inclusions to make. This appears to be a specific hazard when researching areas such as FXS, 
ASD and phenotypic behaviour (Pellicano, Dinsmore & Charman, 2014).  It was also something that 
I could ‘notice’ and refocus from.  After engaging in initial superficial reflective processes (e.g. 
noticing), I applied myself to deeper reflection during the learning process (Moon, 1999).   
  
The inclusion and exclusion criteria required adaptation at a number of stages. The range of current 
research into FXS has developed considerably since the discovery of the FMRI gene and continues to 
do so in line with medical advances in areas such as neuroimaging. Research into BPs also delivers a 
wide range of sub-categories such as; neurobiological causal factors that contribute to the development 
of BP; the impact of family and environmental factors on BP; health needs; efficacy of psychological 
intervention on BP; efficacy pharmaceutical intervention on BP; diagnostic severity – carrier or full-
mutation focus (repeat severity); as well as demographical focus on specifics such as children, adults 
and gender differences. A potential limitation is that due to the enforced specificity, not all findings 
from the systematic review will be applicable across the entire FXS population.  
 
Inclusion criteria that limited the review to peer-reviewed journals were set with the aim of increase 
the quality of publications (Ware. 2008). As such, it could be argued that papers are more likely to get 
published if they report positive findings. This inclusion criteria could potentially bias positive findings 
 93 
over papers that do not report non-significant findings. In contrast, support is offered that most 
unpublished papers tend to be from a result of lower methodological quality than published paper 
(Egger, et al., 2003).  
 
 
Quality Assessment 
 
An appropriate quality assessment tool should be used to ascertain the overall quality of the research 
paper (Sanderson, Tatt & Higgins, 2007). The methodological quality of design and analysis of the 
included research should be assessed to ascertain the level of bias and error (Dissemination, C.R.D, 
2009). Assessing the methodological quality of research into BPs required the use of a review tool 
(Appendix C) developed by Cross and Hare (2013). This tool was developed in the absence of a 
standardised measure to assess the quality of research into BPs and was designed based on principles 
of Best Practice described in literature on BP methodology (Flint 1996). In the absence of a validated 
measure, this was deemed the most suitable option due to its previous acceptance by peer-reviewed 
journals in the area of FXS, ID and ASD. The original number of research papers assessed for 
methodological quality was N=23 (see Appendix D). The final number N = 13 were presented in Table 
1 of paper 1. These research papers were also assessed against additional PRISMA methodological 
guidance for the domains that were appropriate for research into BPs (Moher et al. 2009). All studies 
included were deemed to be of good methodological quality assessed by two independent assessors.  
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Data synthesis  
 
A narrative synthesis was conducted to describe the main findings from the included studies as the 
heterogeneous nature of: the studies; their participants, the BP being measured; their methodology; 
and their assessment measures meant that a meta-analysis couldn’t be achieved (Dissemination, C.R.D, 
2009). Furthermore, the diverse nature of the studies meant that although odds ratio (OR) or effect size 
(ES) was reported in some studies, it was only appropriate to conduct a review of the studies and their 
data analysis, rather than conduct a meta-analysis of their OR’s. To control for potential bias that can 
occur in narrative synthesis (Valentine et al., 2017) I utilised my supervisors for synthesis of chosen 
studies whilst adhering to guidance on how to conduct narrative synthesis (Popay et al., 2006). 
 
Ultimately, this systematic review was limited to cross sectional and cohort studies, with only 2 
longitudinal studies. This is not so much a criticism of the research papers, rather the challenges faced 
in researching BPs. The review did not include intervention studies and consequently, no randomised 
controlled trials (RCTs) were included.  
 
The review was limited to BPs underlying FXS and ASD presentations; however, there is also 
significant comorbidity with FXS and ADHD, which warrants exploring and the overlap with some 
BPs of ASD may provide further insight into understanding FXS.  As such, the review exclusion 
criteria, partly constrained by the word count of the review paper, limited a much broader focus of 
potential underlying mechanisms involved in the development or cause of BP. As highlighted in the 
review, several BPs are present across FXS and iASD all of which worthy of review and inclusion. 
Although every effort was made to synthesise a clear and specific focus, the quantity of BPs discussed 
within a word constrained review paper limited the depth of discussion for each individual BP.  
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A further limitation in the review studies is the weighting of male participants in studies. Although it 
is largely accepted that males diagnosed with FXS are more impaired than females diagnosed with 
FXS, the increased prevalence of ID makes research into BPs more complicated. This aside, the 
imbalanced focus on males, as noted in the review paper, naturally creates difficulties to generalise 
findings across the FXS population. 
 
Finally, to the potential limitation of reliance on parental report for assessment of ASD traits or BPs 
associated with the syndrome (Dillenburger et al., 2010). Some of the studies included parental report 
measures which is unavoidable in research into disorders or syndromes where self-report or 
professional assessment is not possible. To reduce the impact that this may have on the findings the 
methodology tool checked for validation of all measures used in the reported studies.  
 
 
Future research 
 
This review has highlighted some testable hypotheses for future research. Of note the trajectory of 
ASD traits in FXS appears to increase in severity with age, such as, repetitive and restrictive behaviour 
over time in FXS+ compared to FXS; increased severity of impairment in reciprocal social interaction; 
and specific pragmatic language deficits. Although this is starting to be acknowledged, more 
longitudinal studies are needed to transfer these findings to theory.  Future research needs to address 
the limitations of the current review and associated studies while attempting to utilise female 
participants, with a longitudinal focus and minimise the reliance on parental reports of behaviour.  A 
move towards longitudinal studies is needed to test out the trajectory hypothesis arrived at by this 
review.  Research examining the outcomes of interventions for symptoms present across FXS, FXS+ 
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and iASD with a focus on outcomes for underlying biological symptoms, such as the role of cortisol 
may be key to providing further distinction. 
 
Implications for Theory and practitioners 
 
There is an undeniable underdiagnoses in clinical practice of FXS+ (Klusek et al., 2014) and BP that 
mirror ASD can go undiagnosed, reinforcing the demand for clinical services to accept cases based on 
symptomatology, need and QoL as opposed to diagnosis.  While clinical service provision continues 
to be organised based on a categorical system of diagnosis supported by DSM-IV & ICD-10, some 
individuals with FXS may not receive a service that could improve QoL.  The developmental trajectory 
of FXS appears the most significant factor for consideration in clinical practice and future research as 
this review concludes the behavioural phenotype of FXS changes significantly with CA.  Current 
service provision and capacity makes diagnosis for ASD likely to result from assessment at one time 
point in clinical practice, this may exclude children with FXS from relevant services given the 
trajectory of FXS+ symptomology. The current review highlighted the significance of impairment in 
reciprocal social interaction, restrictive and repetitive behaviours, social language difficulties for 
individuals with FXS+.  Specifically, indicating the biological underpinning of social avoidance in 
FXS with indications for the clinical management of the BP.   
 
Clinical guidelines documenting an appropriate diagnostic pathway and associated interventions for 
FXS+ would increase the percentage of diagnoses and subsequent relevant service access for this 
group.  Considering the high prevalence of ASD traits, ID and psychiatric symptoms in individuals 
with FXS, clinical guidelines targeting these presentations would benefit from providing reference to 
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people with FXS and associated assessment and intervention guidelines.  However, the development 
of such interventions relies on further clarification of the evidence base within the literature on FXS.  
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Review of Paper 2: Empirical study 
 
Topic 
 
Following the transformative learning experience (Moon, 1999) of the review of the literature in paper 
1, the principle aim of the research paper was to examine the differences in the behavioural phenotype 
(BP) of boys and girls with a diagnosis of FXS. Research into females with FXS is limited in 
comparison to that of males. Comparison of males and females with a diagnosis of FXS is hypothesised 
to aid greater understanding of the range of BPs of ASD traits present across individuals with FXS due 
to the potential of controlling for cognitive ability. Aiming to compare those who have a diagnosis of 
FXS only (FXS-O) to those participants who have a comorbid diagnosis of FXS and ASD (FXS+ASD) 
three hypotheses were set: 
 
Hypothesis 1: The severity of ASD traits in girls with FXS will be significantly lower from that observed 
in boys with FXS 
Hypothesis 2: The behavioural phenotype of girls and boys with FXS-O will not differ significantly 
from the behavioural phenotype of those with comorbid diagnosis of FXS+ASD.  
Hypothesis 3: Both social communication difficulties and restrictive and repetitive behaviours will be 
positively associated with intellectual disability irrespective of gender.   
 
Ethics 
 
The proposed project was submitted for ethical approval to the Cardiff University School of 
Psychology Research and subsequently approved by the Fragile X Society (FXS-UK) research board. 
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Methodology 
 
Recruitment  
 
This research paper, undertaken in collaboration with Cardiff University and the FXS-UK, was the 
second in a series of studies of FXS in this collaboration. In the first study by Daffin, Thomas, 
Hardiman and Hare (in submission) participants recruited through FXS-UK were asked if (A) they 
consent to be contacted at a later date to take part in both follow up studies and/or new studies and (B) 
if they consented to their data from the original study being made available to other researchers 
working on FXS under the supervision of Dr Hare.  
 
Access to data already gathered by Daffin et al., was dependent on Cardiff University ethics approval 
and consent provided in the original study by participants. The aim was to ensure that participants who 
have already dedicated their time and consented to their data being utilised were relieved from the 
potential burden of being contacted with a request to complete measures already stored on data base. 
In order to build upon the data, set by Daffin et al., this research paper mirrored some of the 
methodology utilised, so data could be merged into a single data set.  
 
As it likely that this collaboration will continue following this project, participants involved were asked 
if they consented for their data from the current study, to be made available to other researchers 
working on FXS under the supervision of Dr Dougal Hare. All participants consented to this, as well 
as their details being stored for future contact which is very positive for future research in this 
collaboration.  
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Participants 
 
The on-line link for the Qualtrics survey was distributed via the FXS-UK and its associated media 
outlets such as Facebook and Twitter and made available for twelve weeks. Additional effort was made 
to specifically promote the study to reach out to female participants with FXS. Additional tweets, 
Facebook posts, and further promotion through the FXS society were made. Completed data was 
returned on 39 boys with FXS and 9 girls with FXS, but total sample number was still relatively low. 
This was significant for the specific aim of comparing male and female participants, with full collected 
data only available for 9 females.  
 
Sample size 
 
Although a sample of N=1500 parents of children with a diagnosis of FXS were potentially be 
accessible via the FXS Society membership database, a relatively low number of participants actually 
completed the on-line platform. A percentage of the accessible parents’ children would no longer be 
under 16. With hindsight, it would be more inclusive to raise this to 25, as per the inclusion criteria for 
studies in paper 1.  This would fall in line with the educational provision as well as offer a greater 
range of data for focus on the developmental trajectory of ASD traits. Changing the age range was not 
possible within the time constraints as it would involve additional ethics approval. Although this 
reduced the power of significance for these findings, the time and effort the participants dedicated to 
completing the measures has contributed to some very interesting findings and will also continue to 
benefit future projects in this series of studies. I would expect that as more data is added from these 
planned studies, the effect size will become more significant. Furthermore, a total of 92 responders 
registered for the platform but duplicates (N=1) and non-complete measures (N=43) were removed 
which drastically reduced the total. Future projects in this series should consider the length of time 
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required to complete the platform (between 20 - 25 minutes) as well as the order of the questions 
contained which is discussed in the measures section.  
 
A final consideration would be the inclusion of international participants, although not excluded from 
this study, a link between FXS-UK and overseas equivalent couldn’t be achieved. In the final week of 
this study, I was contacted by a parent of a child with FXS who lived in America (formally from the 
UK) who would be willing to promote the following study in the series through her membership in an 
FXS society in America. She kindly accessed the link to our study and provided recommendations to 
adapt so that the language would be suitable for both UK and American parents. This feedback will be 
utilised for the following studies.  
 
Measures 
 
The measures utilised in this study included the; Social Responsiveness Scale – second edition (SRS-
2; Constantino and Gruber, 2012); the Repetitive Behavioural Questionnaire 2 (RBQ-2; Leekam et al., 
2007) and the Wessex Questionnaire (Kushlick et al., 1973). 
 
Validity of the measures used in empirical research is paramount. As previously mentioned, measures 
chosen for my empirical paper had already been decided due to benefit of maintaining consistency in 
the data being collected for the series of studies focussing on FXS. However, justification and 
appropriateness for their use in this study was still assessed. The measures were evaluated for efficacy 
with the target population, whilst considering the aims of the study and whether these measures would 
be appropriate in providing the specific data needed to test the given hypotheses. In addition, peer 
accepted studies utilising these measures were sought (Wolfenden, Wittkowski, Jones, Rust, & Hare, 
2019; Moss, Oliver, Arron, Burbidge, & Berg, 2009). Standardisation such as target age and the 
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methodology involved in developing the normative data was checked, as well as the specific process 
required to ensure accurate scoring, interpretation and reporting of the findings (as outlined within the 
measures).  
 
I purchased the SRS-2 so that the study was licenced to use and report on the sub-categories. The SRS-
2 is also sensitive to milder autism spectrum conditions (ASC) and provides a quantitative score for 
comparison across settings and against norms for autistic social impairment. This sensitivity is 
valuable when evaluating the presence of symptoms/BP that don’t meet the threshold required on a 
subjective yes or no evaluation. In addition, the norms for the SRS-2 were established through different 
raters, providing a more robust inter-rater reliability of the established norms. The school-age sample 
included 2,025 ratings of 1,014 children across 16 age levels. 
 
The SRS-2 provides a total score, the most reliable measure for social deficits related to ASD, and 
subscale scores.   The measure had good consistency, validity and reliability data: Strong internal 
consistency was found across gender and age and across clinical subgroups; Content validity was 
strong with the items reviewed by experts representing various fields including special education, 
psychology, paediatrics, child neurology and psychiatry, and parents of children on the autism 
spectrum; Descriptive data and internal consistency were assessed along with mean differences across 
diagnostic categories associated with ASD. The clinical sample obtained raw scores considerably 
higher (M = 106.6) than those who represented the control (M = 24.6): A large effect size (Cohen’s d 
= 2.7) was reported. Ultimately, the SRS-2 does well in identifying those with and without 
characteristics of ASD.  
 
What I like about the SRS-2 is that it’s a validated for its measurement of impairment on a quantitative 
scale of severity, therefore seeing ASD symptoms on a spectrum as opposed to other measures that 
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provide a yes or no decision about the presence of a symptom. The ability to measure the severity of 
social impairment is important for clinical practice as even mild degrees of impairment can have 
significant effects on social functioning. This fits with much of the literature presented throughout the 
systematic review and empirical paper that concluded with the need to focus on symptoms rather than 
categorisation. Due to the reasons outlined above, the SRS-2 was deemed an appropriate measure for 
paper 2.  
 
The RBQ-2 is a four-factor measure which has 20 items, developed to broadly measure unusual sensory 
interests, repetitive motor movements, rigidity/adherence to routine and preoccupations with restricted 
patterns of interests based on based on items from Diagnostic Interview for Social and Communication 
Disorders (DISCO: Wing et al., 2002). It was developed using two geographical subsamples and 
reports good internal consistency (alpha = 0.85), inter-item validity, and across samples reliability 
validity. The coefficient alpha statistics for each of the four sub-scales (repetitive movements alpha = 
0.80; rigidity alpha = 0.75; preoccupations alpha = 0.72; and sensory interest alpha = 0.66) suggest 
acceptable internal consistency. Originally validated for use with 2-year-olds, the RBQ-2 has gained 
acceptance as an appropriate measure for use with children and adolescents with ASD with good 
internal consistency across the whole scale (a=.86) and for both RSMB (a=.79) and IS (a=.83; Lidstone 
et al. 2014). 
 
The Wessex Questionnaire (Kushlick et al., 1973) a questionnaire used to assess several dimensions 
of ability in children and adults with ID. Comprised of five subscales with a total of 15 items 
continence (4 items), self-help skills (3 items), mobility (2 items), speech (1 items), literacy (3 items), 
vision and hearing (2 items) items are scored on a scale from 1 to 3, higher scores indicating a greater 
level of ability. It has good efficacy for use in large scale questionnaire studies with good inter-rater 
reliability at both sub-scale and item level for adults and children (Richards et al 2012). 
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Demographical questions, as well as questions relating to health and support needs based on work by 
Bromley, Hare, Davison and Emerson (2001) were additional items added to the measures in order to 
collate a depth of data for the series of studies in this collaboration. The data collected on the health 
need of these participants was not focal to the aims this research paper but was an essential component 
of the Daffin et al (In preparation). It is possible that due to the order of the questions on the platform, 
health need questions coming first, that data collection on questions for the RBQ-2, SRS-2 and Wessex 
may have been hindered. Partial completers who didn’t complete the entire questionnaire to the end, 
due to the order often missed completing questions on the ASD measures.  
 
 
Data analysis 
 
The findings are impacted upon by the small sample size and unequal distribution of age and sex 
resulting in non-parametric analysis.  Although every effort was made to reduce the burden on the 
families of children with FXS, the study measures were time consuming taking on average 20-25 
minutes to complete. This could explain the relatively high rate of partial responders (N=42 incomplete 
data, participants removed), although this may also be indicative of content or design of the platform 
itself.  The online platform enabled access to an international audience, but recruitment of participants 
to the level that would provide acceptable power (Cohen, 1992) and effect size was not achieved. 
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Implications for research and clinical practice 
 
Within this participant group ASD traits were as prevalent in females as they were in males, 
irrespective of ID. Limitations aside, analysis of the data produced some significant results promoting 
the need to increase the research interest in females with FXS (with or without ASD diagnosis). There 
was also support for the trajectory model of the development of ASD symptoms in FXS over time. 
Clinical implications include the need to assess for ASD later in developmental trajectory if assessment 
earlier on has not indicated ASD.  Future research should expand on gender comparisons, with an 
additional focus on the impact of psychiatric symptoms associated with BP.  A longitudinal focus will 
provide more information about the trajectory of symptoms and inform clinical provision for this client 
group.  
 
These findings can form the basis of direction for the following studies in this collaboration. Data can 
be stored and utilised as consent has been provided. Participants have also provided consent to be 
contacted again which provides an opportunity to conduct a longitudinal evaluation of these 
participants over more than one time point. 
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Personal and professional reflections 
 
Through my experience of 1:1 working with a brilliant and inspiring young woman who had a 
diagnosis of FXS, my professional interest in FXS had been activated. This was heightened further 
when attending a conference for FXS research in Edinburgh. With international experts in the research 
field of FXS presenting, the conference emphasised the global interest in FXS, as well as the 
significance and range of focus. The highlight of the conference was a talk by a parent of two boys 
diagnosed with FXS. He provided an open and honest account of the difficulty’s children with FXS 
and their families face. He balanced this by presenting the individual strengths and characters of the 
boys, whilst highlighting the impact that research has had and continues to have within the area of 
FXS. Whether it has been individuals with FXS, families of these individuals, or professionals with a 
special interest in FXS, the passion and drive of all those I have encountered, triggered personal 
reflections that shaped my professional focus throughout this research project.  
 
Although this empirical paper didn’t require face-to-face contact with the participants, reading some 
of the comments in the completed measures was emotive.  Especially when related to difficulties in 
accessing specialist services for these children and families, often exclusion based on subjective and 
arbitrary categorisation criterion. I can only imagine how difficult it would be if one of my children 
was unable to access specialist services that could improve their quality of life. I didn’t foresee the 
frustration of feeling powerless to intervene and found myself reflecting on the different contributions 
a clinical psychologist can make. Conducting research to contribute to the development of theory to 
guide clinical practice was a change to the direct 1:1 clinical intervention that I am experienced in. 
Although the findings from these papers have clear methodological limitations, they will contribute to 
the literature.  They highlight the need to have equitable focus on females diagnosed with FXS and 
add justification for future research to take a developmental trajectory with regards ASD traits in FXS. 
Ironically, I’m not sure if answering the question of whether ASD traits in FXS represents true ASD 
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would be beneficial for the FXS population, as it could contribute to exclusion from current service 
provision for ASD.  
 
Research dissemination 
 
 
Upon request the research will be made available to any of the participants who have been involved in 
the project. It will also be shared will with the UK Fragile X Society for the benefit of all their 
members. Outcomes will also be presented at their annual UK Fragile X Conference. The research will 
also be disseminated at the UK Annual Seattle Club Conference and at the European Conference on 
Intellectual and Developmental Disabilities conference. The results will also be disseminated within 
the School of Psychology at Cardiff University and the Department of Clinical Psychology. It has been 
agreed to present the findings at the NHS Wales Learning Disability Directorate Special Interest Group 
(SIG) in June of this year. The findings will be disseminated in a user friendly and accessible way via 
the Fragile X Society and its social media outlets. This will involve the creation of a short video and a 
one-page leaflet presenting the results and implications. For service level engagement an SBAR format 
will also be created. It will also invite members of the public to comment on the findings. These will 
then inform future research and further dissemination. 
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Appendix B 
 
Methodology assessment tool
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Methodology quality assessment tool. Cross & Hare (2013). 
Research paper assessed for: Score  
1. Control group  0 = no control group, 1 = comparisons between non-genetically distinct groups or utilise standardised assessment tools, 2 
= genetically distinct control group.  
2. Sample size 0 = fewer than 15 participants, 1=15+, 2=30+. 
3. Recruitment  0 = participants selected by clinician(s), 1 = participants recruited either through charity or medical clinic, and 2 = multiple 
methods, multiple clinics or multiple charities are used for recruitment.  
4. Syndrome diagnosis  0 = syndrome diagnosis based on self-report, 1 = diagnosis based on physical features or sibling diagnosis, 2 = diagnosis 
based on appropriate genetic/enzyme testing.  
5. Methodology  0 = no validated measures are used, 1 = use validated and/or standardised assessment tools, 2 = validated and/or 
standardised measures are used alongside new measures, observations or other methodology. 
6. Considerations for development  0 = participants are compared ‘en mass’, 1 = the study considers age as a variable for at least one aspect of development 
or behaviour, 2 = age is considered as a variable in relation to development and behaviour (or all areas investigated). 
7. Appropriate statistics/ comparisons. 0 = data not analysed, 1 = descriptive statistics are used, 2 = appropriate comparative/correlative statistics are reported. 
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Initial methodology screening table N=23
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Author/ 
Year/  
Country 
Score Study Aims Control 
Group 
Sample 
Size (age 
range) 
Recruitment Diagnosis Methodology Developmen
tal Factors 
Stats Findings 
1.Crawford, 
Moss, 
Anderson, 
Oliver, & 
McCleery, 
2015 
 
 Examine 
individuals with 
FXS and ASD if 
they 
spontaneously 
discriminate 
between facial 
expressions eg 
time looking at 
eyes mouth  
FXS = 13  
 
ASD – 15 
 
TD – children 
= 16 
1 f (mean 
19.7 st 
dev 9) 
 
3 f (11 – 
std 3.4.8) 
 
18 f 
(7.13 – 
std 1.61) 
 
12 adults 
(21.92 
std2.97) 
Cerebra centre 
for fxs and asd  
 
Community 
outreach 
recruitment 
campaign 
 
TD children 
infant & child 
database 
 
TD adults 
research pool 
university 
 
 
ASD ADOS 
 
FXS database 
genetic 
SCQ (rutter 
2003) 
Vineland ABS 
2nd edition 
Survey 
interview form 
(sparrow et al 
2005) 
Demographic 
Q’aire 
Mac Brain face 
stimulus set 
(Tottenham et al 
2009) eye 
tracking task 
Vineland 
instead of IQ 
due to age 
range and 
ability 
 
Difference 
in 
chronologica
l age 
considered 
in 
ANCOVA 
statistical 
analysis 
between 
happy and 
disgust 
preference 
Shapiro-wilk test 
for normality. 
Paired samples t-
tests; (time looking 
at faces on the left 
and faces on the 
right); time spent 
looking at happy vs 
neutral and disgust 
vs neutral). 
Independent 
samples t-test 
compared asd vs 
fxs happy and 
disgust preference. 
ANCOVA with CA 
as co-variant. 
FXS & ASD 
participants higher 
proposition of looking 
disgust over neutral but 
not happy over neutral 
faces 
 
Ancova found no 
difference between 
happy and disgust 
preference according to 
CA 
 
 
 14/14  2 2 2 2 2 2 2  
2.Farzin et al., 
2006 
 Compare 
prevalence of 
ASD and 
ADHD 
symptoms in 
boys with pre-
mutation 
presenting as 
probands, in 
brothers with 
the pre-mutation 
who do not 
present as 
probands and 
normal brothers 
of premutation 
and / or full 
mutation 
carriers 
43 male 
children 
 
(14 probands; 
13 
nonprobands; 
16 male 
siblings of 
individuals 
with FXS who 
were negative 
for mutation) 
 
Mean 
age = 
10.3 +/- 
5.0 
 
14 
probands 
(Age 9.3 
+/- 4.8) 
 
13 
nonproba
nds (Age 
11.5 +/- 
5.1) 
24/43 
University of 
California, 
Davis or 19/43 
La Trobe 
University 
Australia 
Molecular 
testing 
 
Documentatio
n of pre-
mutation allele 
using 
polymmerase 
chain reaction 
(PCR) and 
southern blot 
analysis 
 
Control 
subjects 
confirmed to 
be negative for 
premutation 
 
Nonprobands 
identified 
through 
Molecular 
testing 
 
Cognitive & 
behavioural 
assessments 
(Weschler 
preschool & 
primary scale of 
intelligence 3rd 
edition; Connors 
Parent Rating 
Scale revised 
CPRS-R:S; 
ADHD 
symptoms 
confirmed by 
DSM-IV-TR 
diagnostic 
criteria by 
authors; 
structured 
Effects of 
age and IQ 
examined by 
comparisons 
using the 
Kruskal-
Wallis test, 
which 
revealed no 
significant 
difficulties 
(but 4 
probands 
and 4 non 
probands 
had below 
average 
FSIQ <85) 
Descriptive stats 
 
Results compared 
 
Kruskal-Wallis 
compared SCQ and 
Connors 
standardised T-
score dependant 
variables and 
sample group as 
independent 
variable = 
significant overall 
group differences 
on SCQ and 
Connors T scores. 
Follow up 
comparisons of 
each pair of groups 
was done using 
Mann-Whitney = 
Study indicates pre-
mutation carriers (even 
if don’t present 
clinically) may be at 
increased risk of asd 
and/or symptoms of 
ADHD.  If premutation 
is identified further 
assessment of 
symptoms of ADHD 
social deficits or 
learning disabilities 
 121 
pedigree 
analysis and 
cascade 
testing in FXS 
families after 
proband was 
found 
medical 
interview;  
 
For ASD: 
Lifetime form 
of the Social 
Communication 
Questionnaire 
SCQ; Autism 
Diagnostic 
Observation 
Scales ADOS or 
ADI used to 
assess according 
to DSM-IV-TR 
 
Parent interview 
& school 
records 
non proband boys 
with pre-mutation 
had higher SCQ 
than controls; no 
sig diff in Connors 
scores; difference 
nonproband vs 
proband with pre-
mutation showed 
probands had 
higher SCQ scores 
and difference on 
Connors 
approached 
significance; 
control and proband 
groups showed 
highly sig diffs on 
SDQ and Connors. 
X2 analysis showed 
significant diff 
between proband 
who took 
medication (87%) 
and controls (0%) 
but no diff non-
probands (17%) and 
controls. 
Pairwise 
spearman’s rho – 
no sig correlation 
between 
 14/14  2 2 2 2 2 2 2  
3.Hall, 
Lightbody, 
Hirt, Rezvani, 
& Reiss, 2010 
 To examine; the 
presence of 
autistic 
behaviours; the 
profile of 
autistic 
behaviours in 
FXS by 
comparing rates 
No control 
group but 
utilised 
standardised 
assessment 
tools (e.g. 
compared to 
mean item 
scores for 
120 
children 
(aged 5-
25) 
Across US 
through nation 
FX foundation; 
flyers; local 
contacts; 
research website 
Using PCR 
and southern 
blot DNA 
analysis. 
ADOS & SCQ 
& IQ 
 
Also used 
‘other’ 
methodology: 
FX FMRP 
protein. 
 
Age 
considered 
as a variable 
for; autistic 
behaviour; 
IQ; and all 
areas 
investigated 
 
2 sample T-tests 
 
Multiple regression 
model (RM) 
 
 
Boys & girls show 
lower rates of 
impairment on 
communication and 
interaction items than 
the reference autism 
samples.  
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of individual 
symptoms 
shown by 
individuals with 
FXS to the 
reference autism 
samples 
provided on 
measures; and 
to determine 
whether IQ and 
autistic 
behaviours were 
associated in 
FXS while 
controlling for 
age, medication 
and FMRP 
levels. 
autism sample 
contained in 
the ADOS 
manual. 
 However, no 
development
al trajectory, 
data 
collected at 
one time 
point. 
 
 
IQ was significantly 
negatively associated 
with the SCQ total 
score in boys and girls 
with FXS controlling 
for age, medication and 
FMRP levels 
 11/14  1 2 2 2 2 0 2  
4.Hall, 
Lightbody, 
Huffman, 
Lazzeroni, & 
Reiss, 2009 
 Investigate eye 
gaze avoidance 
is associated 
with high levels 
of hyperarousal 
during social 
interaction with 
50 boys and 
girls with FXS 
aged 5-20 years 
during 25 
minutes 
intensive social 
interaction with 
an unfamiliar 
experimenter 
50 pairs of sex 
matched 
siblings 
 
(26 male / 24 
female with 
FXS & 50 
Same sex TD 
biological 
siblings 
unaffected) 
26 M / 
24 F 
pairs 
 
Sex 
matched 
sibling 
closest in 
age 
 
Age  5-
20 
30 
children 
(60%) 
older 
same sex 
siblings 
19 
children 
(38%) 
had 
Across USA 
and Canada 
National FXS 
foundation; 
flyer to SIG, 
local contacts & 
research website 
Genetic 
testing 
 
CGG repeat 
lengths <40; 
none of the 
siblings were 
carriers of pre-
mutation of 
full mutation 
Heart rate 
monitoring 
device whilst 
watching 10 
min video (last 
5 mins used in 
analysis); 25 
minutes 
conversation 
with researcher 
whilst being 
requested to 
maintain eye 
contact ABABA 
design to variate 
proximity of the 
researcher to the 
participant 0-
2m; 
observations 
recorded using 
software to code 
Sex matched 
with closest 
sibling in 
age; 
chronologica
l age was 
included as a 
covariate in 
2dfWald test 
FXS vs TYP 
compared using 
mixed methods 
regression model 
with random effects 
using XTREG in 
STATA 10 (Stat 
Corp College 
Station TX) 
 
2-dfWald test to 
inspect both 
interactions 
simultaneously; 
chronological age 
and activity counts 
at time T were 
included as 
covariates 
 
FXS significantly 
higher heart rates, 
lower vagal tone & 
lower heart rate 
variability estimates at 
baseline and during 
social interaction vs 
TYP 
Eye gaze avoidance sig 
higher level in FXS; 
but behaviour 
decreased slightly over 
the session and did not 
seem to be associated 
with cardiovascular 
activity. 
Girls with FXS higher 
levels of FXMRP were 
associated with higher 
(and more typical) 
heart rate variability. 
 123 
younger 
same sex 
sibling. 1 
pair non-
identical 
twin 
multiple 
behaviours 
Separate analysis 
for male and female 
subjects 
Conclusion both 
sympathetic and 
parasympathetic 
nervous Systems 
dysregulated in FXS. 
 14/14   2 2 2 2 2 ?validated 2 2  
5.Hatton et 
al., 2006 
 
8 but 
with 
queries  
 
??? 
quality 
of study 
write 
up? 
ASD behaviour 
in children with 
FXS to 
determine 
prevalence of 
Autistic 
behaviour in 
FXS; examine 
the stability of 
ASD ratings 
over time 
(repeated 
measures); 
assess 
association 
between FMRP 
and autistic 
behaviours 
(association 
between protein 
and autistic 
behaviour) 
179 children 
with FXS 
 
Subset: 116 
children with 
396 repeated 
observations 
 
Subset 83 
children to 
examine 
impact of 
FMRP 
 
 
 
 
comparison 
between non 
genetically 
distinct groups 
179 
children 
 
Age in 
months: 
 
Females 
49.4 (SD 
29.3) 
 
Males 
51.9 (SD 
27.9) 
 
Total 
51.6 (SD 
27.4) 
Data from larger 
longitudinal 
study.  
Recruitment 
strategy not 
described. 
FMRP 
collected on 
one occasion 
for 83 children 
– however this 
isn’t specified 
that DNA 
testing has 
taken place to 
confirm the 
diagnosis 
Childhood 
Autism Rating 
Scale (CARS) – 
assessments 
completed twice 
yearly or 
annually in 
schools or 
children’s 
homes 
Age effects 
detected for 
CARS 
scores and 
changes over 
time 
Descriptive stats 
using cross 
sectional data from 
first CARS 
 
Longitudinal data 
analysed using 
HLM (hierarchical 
linear modelling is 
an ordinary least 
square regression 
based analysis that 
takes hierarchical 
structure of the data 
into account) 
 
A baseline model 
was fit predicting 
CARS scores from 
age 
29% of the sample of 
129 scored at or above 
the cut off for Autism; 
CARS scores increased 
slowly but significantly 
over time; lower levels 
of FMRP were 
associated with higher 
levels of autistic 
behaviour 
 /14  ?1  2 - ? 1 2 2  
6. Hernandez 
et al., 2009 
 
  This one  
FXS - ASD 
 
FXS no ASD 
       
7.Hessl et al., 
2001 
 In home 
evaluation of 
120 children (80 
M/40 F) with 
FXS full 
mutation and 
unaffected 
sibling; 
Unaffected 
siblings (62 
girls / 58 
boys) 
120 
children 
(80 M/40 
F; 5 girls 
& 9 boys 
were 
mosaic) 
 
Recruited from 
FXS register; 
advertisements; 
FXS newsletter; 
National FXS 
email; Stanford 
research 
website; 
DNA testing Southern Blot 
analysis 
performed by 
Kimbell 
Genetics 
 
FMRP analysed 
 
Child IQ 
was 
considered 
to account 
for variation 
in the 
behaviour 
attributed to 
Multivariate 
analysis of 
variance. 
Multiple regression 
analysis, to 
examine bivariate 
correlations 
between planned 
Boys with FXS 
effectiveness of 
education and 
therapeutic services 
and parental 
psychological 
problems preicted 
internalising and 
 124 
including 
measurements 
of FMR1 
protein, quality 
of home 
environment, 
maternal & 
paternal 
psychopatholog
y, effectiveness 
of education, 
therapeutic 
services & child 
behavioural 
problems 
6-17 
years old 
 
FXS 
mean = 
10.76 
(SD = 
2.83) 
 
Unaffect
ed 
siblings 
= 11.2 
(SD = 
3.10) 
referrals from 
researcher; 
national FXS 
foundation 
clinicians & 
family 
IQ: WISC-III 
(ages 6-16) 
 
Behaviour: 
Child Behaviour 
Checklist 
 
Parental: The 
Symptom 
Checklist – 90 
revised 
 
Home: Home 
observation for 
measure of the 
environment 
(HOME) 
 
Economic 
status: Parental 
report of gross 
household 
income annual / 
divided by 
medium 
household 
income in the 
area 
 
Education: 
Special 
curriculum 
opportunity 
ratifying scale 
(SCORS) 
development
al disability 
independent 
variable and 
dependent 
variables. 
Variance in 
behaviour problems 
hierarchical. 
multiple regression 
analysis separately 
for boys with FXS, 
girls with FXS and 
comparison 
siblings. 
Hierarchical 
approach to 
bio/genetic vs 
environment: Step 
1: Biological 
characteristics 
(gender IQ & 
FMRP) 
Step 2: 
Environmental 
(quality of home – 
HOME; parental 
psychopathology 
SCL-90-R mean 
score; effectiveness 
of SCORS 
correlation). 
Regressions and 
follow up 
analogous 
regression were 
performed on 
withdrawn, 
anxious/depressed, 
thought & attention 
problem subscales 
of CBCL 
externalising problems; 
quality of the home 
environment predicted 
autistic behaviour 
 
Girls with FXS results 
emphasises sig effect 
of FMRP on behaviour 
esp social withdrawal 
and anxious behaviour 
 
Findings link FMRP 
expression to 
behaviour; also 
emphasises 
significance of home 
and school based 
environmental 
variables in the neuro 
behavioural phenotype 
 14/14  2 2 2 2 2 2 2  
 125 
8.Hustyi et 
al., 2015 
 Relationship 
between autistic 
symptoms and 
independent 
living skills in 
adolescents and 
young people 
with FXS 
35 age and IQ 
matched 
controls 
70 
individua
ls with 
FXS plus 
35 
controls 
 
FXS: 
 
35 males; 
35 
female 
aged 15-
25 
 
35 
controls 
= 16 
male; 19 
female 
 
NIH funded 
longitudinal 
study 
investigating 
functional 
outcomes and 
neuro imagining 
of adolescents 
and young 
adults with 
FXS.  FXS 
participant 
recruited via 
advertisements; 
community 
media and 
national FXS 
foundation. 
 
Control 
=community 
media; state run 
agencies for 
individuals with 
developmental 
disabilities 
Confirmed 
diagnosis of 
FXS 
(Southern Blot 
DNA analysis) 
 
Controls were 
screened to 
confirm no 
FXS and no 
diagnosis of 
unknown  
genetic 
disorder 
Independent 
living skills: 
Independent 
living scales 
 
Autistic 
symptoms: 
ADOS (Lord et 
al. 2000) 
Matched 
aged and IQ 
controls 
 
Balance 
groups on 
degree of 
autistic 
symptoms 
meant that 7 
males with 
highest 
autistic 
symptomolo
gy on ADOS 
excluded 
 
Control for 
IQ 
conducted 
correlation 
analysis in 
which IQ 
was included 
as control 
variable 
Correlation analysis 
of the data for 
autistic 
symptomology and 
independent living 
skills by pearson 
correlation between 
total score on 
ADOS and raw 
scores on ILS 
 
Control for IQ 
conducted 
correlation analysis 
in which IQ was 
included as control 
variable 
 
To compare 
correlation 
coefficients 
between groups 
Fishers r-t-z 
transformation was 
used.  
Higher levels of 
autistic symptomology 
associated with lower 
levels of competence in 
independent living 
skills in individuals 
with FXS but not in 
control groups 
 
Data indicates 
relationship between 
autistic symptomology 
and independent living 
skills was syndrome 
specific 
 14/14  2 2 2 2 2 2 2  
9.Kau et al., 
2004 
 
 
Distinctive SBP 
of boys with 
FXS, if so does 
age effect SBP 
when compared 
FX cohort 
3 groups: FXS 
with ASD; 
DLD with 
ASD; & 
idiopathic 
ASD 
55 – FXS 
 
22 – 
DLD 
 
11 - 
Idiopathi
c  
Kennedy 
institute 
 
‘word of mouth’ 
 
American ASD 
society 
 
Genetic 
testing.  
 
Southern 
blotting 
techniques. 
S/VM 
 
No 
development
al trajectory, 
data 
collected at 
one time 
point. 
However, 
SBP 
stratified by 
age 
DS 
 
BC 
 
WC 
FXS & ASD & more 
generally SBP is a 
distinctive sub-
phenotype amongst 
boys with FXS  
 11/14  = 2 = 2 = 2 = 2 = 1 = 0 = 2  
10.Kaufmann 
et al. 2017) 
 Impact of ASD 
diagnosis in 
2 groups: 
 
Cross 
sectional 
(FORWARD) 
Multisite 
Full details for 
enrolment for 
Clinician & 
parent report 
Data 
analysis 
X2 tests for 
association; t tests; 
Conclusions: Greater 
frequency of seizures 
 126 
clinic based 
FXS population 
 
Compared: 
frequency of 
seizures 
occurring at any 
age; sleep 
problems 
enquiring meds 
or treatment; 
cooccurring 
behavioural 
problems; 
(including 
attention 
deficits, 
hyperactivity, 
hyper 
sensitivity, over 
reactivity, 
anxiety, 
obsessive 
compulsive 
disorder, 
perseverative 
behaviour, 
mood swings, 
depression, 
irritability, 
aggression) 
Aged 3-11 
n=348 
 
Aged 12-21 
n=199 
data on 
713 
subjects 
with FXS 
(from 
sept 
2012-
august 
2014); 
followin
g 
exclusion
s almost 
600 
eligible  
observational 
study that 
includes a 
registry and 
longitudinal 
database using 
standardised 
clinician and 
parent report 
data  submitted 
by 25/27 
specialty clinics 
across the US 
affiliated with 
Fragile X clinic 
and research 
consortium  
 
full details for 
enrolment for 
FORWARD 
presented in 
Sherman et al. 
(2017) à  
 
Recruitment is 
clinic based, 
with individuals 
attending 
specialty clinics 
approached 
FORWARD 
presented in 
Sherman et al. 
(2017) 
 
Sherman 
reports that 
participant 
enrolled on 
longitudinal 
database are a 
subset of those 
on the registry 
who have been 
diagnosed 
with the full 
mutation 
 
ASD 
diagnosis from 
FORWARD 
clinician 
report 
 
form (yearly 
clinic visit) 
Parents asked 
about provision 
of services to 
participant at 
school years 
(special ed; 
speech & 
language, OT, 
sensory 
integration, 
physical 
therapy, 
psychological/b
ehavioural 
programme, 
social skills 
therapy, 
program, 
tutoring or 
ABA) 
3 standardised 
parent report 
measures: 
Social 
responsiveness 
scale second 
edition (SRS-2); 
social 
communication 
questionnaire 
(SCQ) Aberrant 
Behaviour 
Checklist, 
Community 
edition. 
conducted 
for child 
group (3-11) 
and 
adolescent / 
adult group 
(12-21), 
‘because the 
impact of the 
asd 
diagnosis on 
certain 
parameters 
may differ 
by age’. 
& a multiple 
logistic regression 
to examine 
association between 
clinical and other 
factors with asd 
status 
 
Multiple regression 
for multivariate 
analyses related to 
use of services and 
ASD status 
and certain behavioural 
cooccurring conditions 
eg. 
Aggression/disruptive 
behaviour in indivs 
with FXS and ASD 
have considerable 
impact on 
management; underuse 
of behavioural services 
in some indivs is 
concerning considering 
core nature of ASD and 
associated challenges 
 13/14  1 2 2 2 2 2 2  
11. Klusek, 
J., Martin, G. 
E., & Losh, 
M. (2014).  
 Consistency 
between 
research and 
clinical 
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 diagnoses of 
autism among 
boys and girls 
with fragile X 
syndrome.  
12.Lee, 
Martin, Berry-
Kravis, & 
Losh, 2016 
 How 
manifestation of 
ASD related 
phenotypes may 
change over 
development: 
characterise 
ASD 
phenotypes in 
boys and girls 
with FXS over 
development 
and compare 
individual 
component 
phenotypes 
among boys 
with FXS vs 
boys with 
idiopathic ASD 
over time (Time 
1 and Time 2 = 
2.5 years apart) 
2 groups: 
 
FXS group (31 
M; 34 F) 
 
ASD-O group 
(19 M) 
 
Time1: 
FXS-girls = 34 
FXS-O =24 
FXS-ASD = 
10 
 
FXS-boys = 
31 
FXS-o=14 
FXS-ASD=17 
ASD-boys=19 
 
Time 2: 
FXS-girls=34 
FXS-o=20 
FXS-ASD = 
14 
 
FXS-boys = 
31 
FXS-o=6 
FXS-ASD=25 
ASD-boys=19 
 
65 boys 
and girls 
with 
FXS: 
 
FXS girls 
n=34; 
age = 
8.96 
(SSD=3.
39) 
 
FXS 
boys 
n=31; 
age = 
8.97 (SD 
= 2.51 
 
19 boys 
with 
ASD-O 
 
Age = 
9.08 
(SD=2.3
1) 
Advertisements 
at genetic 
clinics and 
physicians’ 
offices, 
advocacy 
groups and 
participant 
registries 
FXS: Genetic 
testing not 
explicitly 
stated, but 
recruitment 
from genetic 
clinics. 
 
 
ASD: 
Previous 
clinical 
diagnosis 
confirmed 
through direct 
assessment wit 
ADOS and/or 
ADI-R and no 
known ASD 
related  
monogenic 
disorders 
ASD 
classification: 
 
ADOS and 
ADI-R 
 
Cognitive & 
language 
abilities: Leiter 
International 
Performance 
Scale Revised; 
Expressive 
Vocabulary 
Test; Peabody 
Picture 
Vocabulary test 
3rd or 4th ed; 
Pragmatic 
judgement 
subtest of the 
Comprehensive 
assessment of 
spoken language 
(CASL) 
Main effects 
of 
chronologica
l age and 
mental age 
using 
hierarchical 
linear 
modelling 
(HLM) 
 
(Looked at 
mental age 
predicting 
symptom 
severity) 
Compared 2 time 
points mean 2.5 
years apart. 
McNemar’s test of 
classification 
assessed rates of 
ASD and whether 
rates of agreement 
between ADOS and 
ADI-r changed over 
time. 
Nonparametric tests 
assess mean 
changes in 
classification in 
FXS over time; 
hierarchical linear 
modelling (HLM) 
and repeated 
measures asses 
changes in 
individual ASD 
symptoms in FXS 
over time.  
ANCOVAS 
compared ASD 
symptoms severity 
and component 
phenotypes in boys 
with FXS-O, ASD-
O, FXS-ASD at 
both time points 
Importance of adopting 
a developmental 
perspective when 
investigating shared 
behaviour features 
across disorders. 
 
ASD symptoms 
increased in FXS with 
age; social language 
impairment emerged as 
a potential core shared 
feature of FXS and 
ASD, which may 
elucidate underlying 
molecular genetic 
variation related to 
phenotypic variants. 
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13..Martin et 
al., 2017 
 Ability to signal 
non-
comprehension 
across different 
FXS 
DS 
ASD 
TD (input age) 
M=121 
 
F=81 
 
Research 
participant 
universities, 
parental support 
Full mutation Cognition & 
Language: Brief 
IQ composite of 
the Leiter 
rANCOVA 
= nonverbal, 
mental ages 
and 
Repeated measures 
analysis of 
covariance 
(rANCOVA) – 
Youth with FXS 
without ASD and those 
with ASD-O did not 
differ from TD; no sex 
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types of 
confusing 
message 
conditions in 
child and 
adolescents with 
FXS, DS, ASD 
and TD  
 
9 groups based 
on sex and 
diagnosis 
 
(NB. 
Participants 
with DS or TD 
who scored as 
ASD were 
excluded) 
With and 
without 
ASD 
groups, genetic 
clinics, 
childcare 
centres and 
schools. 
Revised 
Peabody picture 
vocab tests. 
 
ASD: ADOS 
and ADI-R 
 
Noncomprehens
ion signalling 
task: The 
Barrier Task 
(Abbeduto et 
al.) 
receptive 
vocabulary 
age. 
 
Controlled 
for mental 
age 
nonverbal, mental 
ages and receptive 
vocabulary age. 
Sex effects were 
assessed within 
diagnostic category. 
Follow up 
ANCOVAS and 
post hoc 
comparisons.  
Mauchley’s test and 
Greenhouse-Geisser 
reported for all 
comparisons and 
conditions. 
Linear regression. 
differences were 
detected in any group.  
Findings contribute to 
current knowledge of 
pragmatic profiles and 
different forms of 
genetically based 
neurodevelopmental 
disorder associated 
with ID. 
Youth with comorbid 
FXS and ASD and 
those with DS were 
less likely that TD 
controls to signal non-
comprehension of 
confusing messages. 
 14/14  2 2 2 2 2 2 2  
14.Martin, 
Bush, Klusek, 
Patel, & Losh, 
2018 
 Multimethod 
approach to 
language sample 
analysis to 
characterise 
syndrome and 
sex specific 
profiles across 
FXS & ASD 
and FXS-O and 
DS and TD 
ASD-O 
FXS & ASD 
n=61 (46 boys 
/  
15 girls) 
 
FXS-O n=40 
(13 boys/27 
girls) 
 
DS n=42 (20 
boys/22 girls) 
 
TD n=37 (19 
boys / 18 
girls) 
 
ASD-O n=29 
(29 boys) 
M=Mean 
10.4 SD 
2.4 
F=Mean 
9.3 (SD 
3.8) 
M=9.7 
(SD 3.3) 
F= 9.5 
(SD 3.7) 
M=10.9 
(SD 2.1) 
F=9.2 
(SD 2.2) 
M=4.7 
(1.0) 
F=5.4 
(SD 2.5) 
M=9 (SD 
2.4) 
Large scale 
longitudinal 
study recruited 
from parent 
support groups, 
child care, 
schools, 
research 
registries and 
genetic clinics.  
FXS = full 
mutation 
 
TD and DS 
groups 
excluded if 
met criteria for 
ASD 
 
TD = no 
history of 
developmental 
of language 
delays 
ASD: 
ADOS 
 
Cognitive & 
structural 
language 
abilities: Leiter 
Revised 
Peabody picture 
vocab tests. 
Expressive 
vocabulary test.  
Analysis 
controlled 
for non-
verbal 
mental age, 
receptive 
and 
expressive 
vocabulary 
age 
equivalents 
and mean 
length of 
utterance. 
Series of analysis of 
covariance 
(ANCOVA) 
controlling 
nonverbal mental 
age and structural 
language; 
ANCOVAs 
addressed group 
difference for 
M&F; cohens D 
(effect sizes).For 
each of the groups 
and all groups 
combined bi-variate 
correlation between 
hand coding and 
conceptually related 
SALT variables. 
Non-continent 
language and 
perseveration were 
characteristics of the 
pragmatic profiles of 
boys and girls with 
FXS and ASD and 
boys with ASD only.  
Boys with ASD only 
also initiated turns les 
often and were more 
non-responsive than 
other groups; girls with 
FXS ASD ere more 
non responsive than 
male counterpart 
 14/14  2 2 2 2 2 2 2  
 129 
15.McDuffie, 
Thurman, 
Hagerman, & 
Abbeduto, 
2015) 
 Which current 
symptoms of 
ASD differed in 
boys with FXS 
relative to same 
aged boys with 
ASD. 
 
FXS n=49 
 
ASD n=39 
Age: 
(Over all 
between 
4 and 10 
years) 
 
FXS = 
7.5 (SD 
2.03) 
 
ASD = 
7.27 (SD 
1.9) 
 
 
Sample drawn 
from larger 
longitudinal 
study examining 
learning in 
males with FXS 
(n=57) and non-
syndromic ASD 
(n=61) 
 
Recruited 
nationally and 
tested at 2 test 
centres. 
Fxs full 
mutation 
genetic  
 
ASD – genetic 
screening to 
rule out FXS – 
diagnosis of 
asd (ADI-R 
and ADOS) 
Nonverbal 
cognition: brief 
IQ screener; 
leiter 
international 
performance 
scale revised. 
 
ASD: ADI-R & 
ADOS 
 
 
Chronologic
al age 
matched 
group for all 
areas 
investigated 
Mann-Whitney U 
test to evaluate 
between group 
differences. 
 
Descriptive stats; 
significance levels; 
corresponding 
effect sizes. 
Boys with FXS show 
sig less impairment in 
social smiling than did 
age, severity and 
diagnostic boys with 
non-syndromic ASD 
 
Severity matched boys 
with FXS showed more 
impairment in complex 
mannerisms than boys 
with non-syndromic 
ASD 
 
 14/14  2 2 2 2 2 2 2  
16.Oakes et 
al., 2016 
 Examine the 
profile 
intercorrelations 
and predictive 
correlated of 
repetitive 
behaviours in 
boys with FXS 
39 boys with 
FXS (repeated 
measures 
design time 
1/time 2) 
FXS 
group 
n=39 
ages 6-10 
years 
(Mean 
7.41) 
Sample drawn 
from larger 
longitudinal 
study; recruited 
nationally using 
variety of 
sources 
including 
newspaper 
adverts, flyers, 
uni research. 
Confirmed 
diagnosis of 
FMR1 
(genetic 
testing) 
2 time intervals 
(T1 & T2) 
At time 2: 
Nonverbal 
cognitive 
ability: Leiter – 
R 
Maladaptive 
behaviours: 
Anxiety and 
depression and 
Mood scale 
(ADAMS) 
ASD: 
ADOS 
At Time 2: 
Revised 
Repetitive 
Behaviour 
Scales Revised 
(RBS-R) 
Compare 
time 1 and 
time 2;? 
Freidman’s analysis 
of variance was 
used to determine if 
repetitive 
behaviours differed 
as a function of the 
RBS-R subscale. 
 
Analysis followed 
up by Wilkoxon 
ranked sum test 
between subscale. 
 
Spearman rank 
correlations 
Some classes of 
repetitive behaviours 
were more problematic 
than others eg. 
Ritualistic and sensory 
motor behaviours 
frequently endorsed as 
problematic; self injury 
least reported as 
problematic 
(Consistent with Wolk 
et al 2012) 
 11/14  0 2 2 2 2 1? 2  
17.Roberts et 
al., 2009) 
 Examine 
environmental 
and 
nonendocrine 
FXS 
 
FXS & ASD 
 
? review 
table 1?? 
Recruited from 
Carolina FXS 
project – a 
series of 
Full mutation 
based on DNA 
testing for all 
SAS – Social 
Approach scales 
- time sensitive 
experimental 
Groups were 
age matched 
and age was 
used as a 
ANCOVA to 
examine SAS 
scores at initial and 
familiar assessment 
Poor social approach 
and elevated baseline 
salivary  and regulatory 
cortisol are discernible 
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factors that 
convey 
increased risk of 
elevated autistic 
behaviour in 
boys with FXS.  
3 related 
analysis 1 
examination of 
multiple 
dimensions of 
social approach 
behaviours and 
how they vary 
over time; 2 
invetsigation of 
mean levels of 
salivary cortisol 
levels; 3 
examination of 
social approach 
and autistic 
behaviours to 
salivary cortisol 
TD  
 
(all boys) 
longitudinal 
studies that 
recruited 
children across 
US through 
Parent FXS list 
(University of N 
Carolina FXS 
registry). FXS 
support groups, 
FXS clinics and 
research 
projects 
FXS 
participants 
measure of 
multiple forms 
of social 
approach 
behaviour 
 
Adaptive 
Behaviour – 
Vineland 
Adaptive 
Behavioural 
Scales  
Cortisol  - 2 
samples of 
salivary cortisol 
CARS – widely 
used reliable 
measure of ASD 
in children 
covariate 
when age 
differed 
intervals 
(controlling for age) 
 
Regression of 
CARS total scores 
 
ANCOVAs to 
examine cortisol 
levels as initial and 
regulation 
assessment 
intervals  
 
Cortisol levels and 
correlation with 
SAS and CARS for 
the 2 groups with 
FXS were analysed 
using multiple 
regression with age 
controlled for. 
traits that distinguish 
boys with FXS and 
ASD from boys with 
FXS only from TD 
boys 
 
Blunted cortisol change 
is associated with 
increased levels of 
autistic behaviours 
only within FXS and 
ASD group. Bos with 
FXS and ASD have 
distinct behavioural 
and neuroendocrine 
profiles differing from 
those with FXS alone 
and TD boys. 
 12/14  2 ?? 2 2 2 2 2  
17.Roberts et 
al., 2018) 
 Social anxiety 
and FXS and 
association with 
ASD;  
N=77  
 
FXS n=59 
 
ASD n=18 
Age 
range 15-
23 (Mean 
18.18 SD 
2.3) 
Longitudinal 
multisite study 
Full mutation 
genetically 
tested  
-Social 
Avoidance 
scale. 
-Baseline 
cortisol level. 
-Anxiety & 
depression & 
mood scale 
(ADAMS) 
-ADOS -2 
-Leiter 
international 
performance 
scale revised 
Check  -Descriptive stats 
-Multivariate 
outcome analysis 
on covariance 
(ManCOVA) 
-Levens test of 
homogenity  
-Tukey Honestly 
Significant 
Different for 
multiple 
comparisons 
-Linear 
discriminate 
functional 
coefficient 
-ANOVA 
Look at summary 
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19.Rogers, 
Wehner, & 
Hagerman, 
2001) 
 Examine 
symptoms of 
ASD and 
relationships 
between ASD 
symptoms and 
developmental 
variables in 
young children 
with FXS 
3 genetically 
distinct 
groups; 
 
-27 
participants 
ASD 
-23 with other 
developmental 
delays. 
-24 with FXS 
30+ 
 
Age: 21 
months – 
48 
months 
Multiple 
measures. 
ADI-R. 
ADOS. 
 
Genetic 
testing for 
FXS group but 
not for control 
group 
S/VM: ADI; 
ADOS; 
Vineland; 
Mullen. 
 
Other measures 
used but not 
reported. 
Although 
age closely 
ranged 
groups 
compared 
‘en mass’. 
No 
development
al trajectory, 
data 
collected at 
one time 
point. 
DS 
 
BC 
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20.Thurman, 
McDuffie, 
Hagerman, & 
Abbeduto, 
2014) 
 Examine 
psychiatric 
symptoms in 
boys with 
fragile FXS 
using a parent 
report 
instrument.  
 
41 – FXS 
group 
41 -  
nonsyndromic 
ASD 
FXS 41 
males 
aged 
4.06–
10.63 
years (M 
= 7.24, 
SD = 
2.04).  
41 
participa
nts with 
nonsyndr
omic 
ASD in 
the Full 
Sample 
ranged in 
age from 
4.02 to 
10.99 
years (M 
= 7.46, 
SD = 
1.76).  
 
 
Large scale 
research project 
but described in 
detail 
 
Recruitment 
through 2 
university sites 
FXS: Genetic 
diagnosis for 
FXS 
 
ASD: 
screened to 
exclude FXS 
 
ADOS for 
ASD 
diagnosis 
Leiter NVIQ SS 
ADOS  
ADAMS (2003) 
? -Friedman’s 
Analysis of 
Variance 
(ANOVA). 
-Results of follow-
up Wilcoxon tests  
-Mann Whitney U 
tests were used to 
address  
-Differences in 
psych symptoms 
between FXS & 
ASD group 
-Spearman 
correlation 
coefficient for 
within-group 
associations  
-A Fisher r-to-z 
transformation to 
determine if 
significant 
between-syndrome 
differences were 
observed in the  
symptoms of 
manic/hyperactive 
behaviours and general 
anxiety more 
frequently reported for 
FXS than ASD. 
Also positive 
association between 
social avoidance and 
general anxiety in FXS 
than ASD 
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strengths of 
association between 
psych symptoms  
 12/14  2 2 2 2 2 0? 2  
21.Thurman, 
McDuffie, 
Kover, 
Hagerman, & 
Abbeduto, 
2015a 
 Aims to 
compare the 
profiles of ASD 
relative to age 
(CA), nonverbal 
IQ, and 
expressive 
vocabulary 
ability between 
FXS and i 
nonsyndromic 
ASD  
 
53 boys FXS 
 
39 boys with 
ASD 
53 boys 
FXS 
39 boys 
with 
ASD 
 
4-11 
years in 
both 
groups 
Recruitment 
through 2 
university sites 
Document of 
proof for 
Genetic 
testing  
 
ASD: 
screened to 
exclude FXS 
 
ADOS and 
ADI-R for 
ASD 
diagnosis 
ADOS and 
ADI-R for ASD 
 
Leiter-R Non-
verbal IQ 
 
Expressive 
Vocabulary test 
Cross 
sectional 
development
al 
trajectories 
to compare 
ASD 
symptoms 
relative to 
chronologica
l age 
States uses 
procedures used in 
Thomas et al 2009. 
Look up 
Results suggest that the 
onset of ASD 
symptoms and their 
developmental trajec- 
tories in males with 
FXS differ in important 
ways as a function of 
CA, nonverbal 
cognitive ability, and 
expressive vocabulary 
relative to males with 
nonsyndromic ASD. 
 12/14  2 2 2 2 2 2 ?  
22.Thurman, 
McDuffie, 
Kover, 
Hagerman, & 
Abbeduto, 
2015b 
 Evaluate the 
ability of Males 
with FXS, ASD 
& typical 
development to 
learn new words 
by using cue 
Males with; 
FXS (n = 32) 
nonsyndromic 
ASD (n = 32) 
or TD (n = 
32).  
 
FXS: 
7.29 
(2.03, 
4.06–
10.32)  
 
ASD: 
7.37 
(1.87, 
4.02–
10.86)  
 
TD: 3.93 
(1.09, 
2.05–5.8)  
 
 
Recruitment 
through 2 
university sites 
Document of 
proof for 
Genetic 
testing  
 
ASD: 
screened to 
exclude FXS 
 
ADOS and 
ADI-R for 
ASD 
diagnosis 
Leiter-R 
 
Peabody picture 
vocab test 4th 
edition 
 
ADAMS 
ADOS 
 
SCQ 
CA as 
predictor 
variable in 
all areas 
investigated 
 
-Fast mapping task. 
-Wilcoxon signed-
rank tests to 
compare each 
groups performance 
-Mann-Whitney U 
test for between 
group differences 
-Aligned Rank 
Procedure to 
compare successful 
search performance 
between ASD & 
FXS after 
controlling for ASD 
severity 
-Chi square for 
evaluating group 
level findings could 
be replicated 
-One sample 
Wilcoxon for 
Performance for all 
groups exceeded 
chance-levels in both 
search conditions. In 
the Successful Search 
condition, participants 
with nonsyndromic 
ASD performed 
similarly to participants 
with FXS after 
controlling for severity 
of ASD. In the 
Unsuccessful Search 
condition, participants 
with FXS performed 
significantly worse 
than participants with 
nonsyndromic ASD, 
after controlling for 
severity of ASD.  
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comparisons 
relative to chance 
 14/14  2 2 2 2 2 2 2  
23.(Wolff et 
al., 2012) 
 Similarities and 
differences in 
behavioural 
expression of 
autism in FXS 
and idiopathic 
Autism (iAut). 
Control group 
group of 38  
boys with iAut 
23 males 
with FXS 
 
38 males 
with iAut 
Multiple 
methods eg. 
Universities, 
TEACCH and 
area clinics 
Southern 
blotting 
techniques 
 
FMRP (FX 
protein 
expression) 
S/VM (ADOS; 
RBSR; Mullen) 
No 
development
al trajectory, 
data 
collected at 
one time 
point. 
DS 
 
BC  
 
 
Supports findings that 
phenotypical 
heterogeneity of autism 
and its unique 
presentation in FXS. 
 11/14  2 2 2 2 1 0 2  
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Appendix D 
Qualtrics 
  
 
Due to the size, a sample of the first 5 pages of the online questionnaire is provided. Full 
questionnaire available on request. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 135 
A comparison of Behavioural phenotypes of ASD 
traits in boys and girls diagnosed with Fragile X 
syndrome. 
 
 
Survey Flow 
Standard: Participants Information  
Standard: Consent to Participation  
Standard: Demographics  
Standard: Needs Assessment  
Block: Repetitive Behaviours  
Standard: SRS- 2  
Standard: Wessex Questionnaire  
Standard: Debrief  
Page Break  
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Start of Block: Participants Information 
 
Q1 Participant Information Sheet.  
A comparison of behavioural phenotypes of ASD traits in boys and girls with a diagnosis of Fragile 
X syndrome (FXS).   
 
Research Team: Dale Thomas, and Dr Dougal Hare (Cardiff University).  We would like to invite you 
to take part in our research study. Joining the study is entirely your choice. Before you decide to 
take part, we would like you to understand why the research is being done and what it would 
involve.   
 
What is the purpose of the study? The purpose and aim of the study are to develop a better 
understanding of the behaviour exhibited by people who have Fragile X syndrome (FXS) when 
compared to the behavioural phenotype of people who have an Autism Spectrum Disorder (ASD) 
diagnosis.  To better understand FXS, the behaviour traits of boys and girls diagnosed with FXS will 
be recorded by asking parents or carers to complete questionnaires relating to the traits they see. 
Separate groups will be created in order to understand the effects that intellectual disabilities and 
severity of ASD symptoms may have on behaviour for people diagnosed with FXS. This will allow 
better understanding of the similarities and differences in behaviour between people who have 
been diagnosed with FXS when compared to people with an ASD diagnosis.  The study also aims to 
compare the observable characteristics of boys diagnosed with FXS with that of girls diagnosed 
with FXS. Girls (XX) tend to have a milder presentation of FXS as they have one healthy X 
chromosome alongside the mutated X chromosome. Boys (XY) do not have the extra unaffected X 
chromosome. This appears to result in an increased likelihood of intellectual disabilities. Comparing 
observable traits of boys and girls with FXS will improve our understanding of gender differences 
and enable us to analyse the impact of variables such as degree of intellectual disability and autistic 
traits.  
 
Why have I been invited to take part in this study? 
You have been invited to take part because you are part of the Fragile X Society research list and 
have previously given your permission to be contacted to take part in research related to FXS. By 
being on this list we have assumed that you are a parent of a child with FXS. We are looking for 
parents whose children are under the age of 16 and have a confirmed diagnosis of FXS who live in 
the UK.  
 
Do I have to take part? 
No, you do not have to take part in the study if you do not want to. Taking part in the research is 
voluntary; this means it is completely up to you to take part. Your decision to participate in this 
study will not be connected to the care you and your family are receiving now or in the future. If 
you decide to take part and sign the consent form but change your mind later, you are free to 
withdraw at any point and do not need to give us a reason. There will not be any consequences to 
your current or future treatment if you decide to do this.   
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Q2 What will participation involve? 
Parents/ carers will complete a set of questionnaires, which ask about their demographic details, 
your child's FXS presentation, if you feel you are receiving the right (or enough) support, and if you 
feel you are receiving the right (or enough) support for your child’s education and health needs. 
Together, these questionnaires will take about 30 minutes to complete. If you are completing 
paper copies you will be provided with a pre-paid envelope to return the questionnaires.  
  
What are the possible disadvantages and risks of taking part?  
It is possible that the questionnaires might raise issues that could be distressing to think about. A 
list of agencies and people you can contact is provided should you need any additional 
information/support. 
  
  
What are the possible benefits of taking part? 
The information gained will help services to better understand the needs of a child with FXS and 
identify ways services can help better meet those needs. This will help clinicians to develop 
appropriate support packages, which may help other families in the future. 
  
  
Will my taking part in the study be kept confidential?  
Yes. We will handle data sensitively and in confidence and follow legal and ethical guidelines. All 
data collected about you and your child will be kept strictly confidential and only viewed by 
members of the research team.  It will be stored securely in a locked filing cabinet at the University. 
Data will be entered onto a computer database which will be password protected and 
encrypted. Each participant will be assigned a number; thus, names will not be entered onto the 
database. We plan to publish the research and names of participants will not be used. All published 
data will be anonymous. 
 
What if there is a problem? 
It is unlikely that anything would go wrong, but if you have a concern about any aspect of the study, 
you should contact one of the researchers. If you are not satisfied and wish to make a formal 
complaint, you can do so through the Cardiff University School Research Ethics Committee 
complaints procedure. Details can be obtained from the University by calling 029 2087 4000. 
In the event that something does go wrong and you are harmed during the study and this is due to 
somebody’s negligence, then you may have grounds for a legal action for compensation against 
Cardiff University, but you might have to pay your legal costs. 
  
Will I receive any payment for taking part in the study? 
Participants will not receive any payment for taking part. 
   
 
Who is organising the research? 
This research is being conducted as part of the Doctorate in Clinical Psychology at Cardiff University 
for Trainee Clinical Psychologist/postgraduate student Dale Thomas. This study will be carried out 
under the guidance of Dr Dougal Hare (Academic Supervisor). It is funded by Cardiff University. 
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Where will the findings be published?  
We intend to publish the results in peer-reviewed journals. We intend to present the results at 
scientific and other relevant conferences. We may put a summary of the findings in the Fragile X 
Society newsletter. We will provide participants with a summary of the findings if they would like 
this.  
 
Who has reviewed the study?                                         
All research in the NHS is looked at by an independent group of people, called a Research Ethics 
Committee who protect the rights, safety, dignity and wellbeing of participants.  This study has 
been reviewed and given a favourable opinion by the Cardiff University School of Psychology 
Research Ethics Committee. 
  
Who can I contact for further information? 
If you would like to discuss the study or have any questions or concerns, please do not hesitate to 
contact Dale Thomas via email on thomasdn@cardiff.ac.uk or tel. 02920 870582. Alternatively, you 
can contact Dr Dougal Hare, Department of Clinical Psychology, 11th Floor Tower Building, Park 
Place, Cardiff University, Cardiff CF10 3AT. 
 
 
End of Block: Participants Information 
 
Start of Block: Consent to Participation 
 
Q3 Please write your name below 
 
 
Q4 The following questions relate to your consent to participate in this study. 
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 Yes (1) No (2) 
I confirm that I have read the 
information sheet for this above 
study. I have had the 
opportunity to consider the 
information, ask questions and 
have had these answered 
satisfactorily. (1)  
o  o  
I understand that I can withdraw 
from the study at any time and 
have my data removed, without 
necessarily having to give 
reasons for this, and that there 
would not be any adverse 
consequences of doing so (2)  
o  o  
I understand that data collected 
during the study may be looked 
at by individuals from Cardiff 
University where it is relevant to 
my taking part in this research. I 
give permission for these 
individuals to have access to my 
data. (3)  
o  o  
I understand my participation is 
anonymous and my 
confidentiality will be upheld at 
all time.  (4)  
o  o  
I agree to take part in the above 
study. (5)  o  o  
 
 
 
 
Q5 Please sign in the box (with your mouse or on touch screen) below to confirm the answers 
above as your own.  
 
End of Block: Consent to Participation 
 
Start of Block: Demographics 
 
Q6 What is the first part of your postcode (e.g. CF10)? 
________________________________________________________________ 
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Q7 What is your relationship to the child you are answering this question about? 
(If you have more than one child with FXS please complete two separate surveys, one for each child 
you wish to include.)  
o Parent (1)  
o Other family member (2)  
o Carer (3)  
o Residential/Hostel Staff (4)  
o Other (5)  
 
 
 
Q8 Is your child: 
o a girl (1)  
o a boy (2)  
 
 
 
Q9 How old is your child? 
o 0-5 years old (1)  
o 6-10 years old (2)  
o 11-15 years old (3)  
 
 
Q10 Does your child have a diagnosis of Autism Spectrum Condition / Autism? 
o Yes (1)  
o Currently under/awaiting Assessment (2)  
o No (3)  
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Participant Information Sheet  
 
A comparison of behavioural phenotypes of ASD traits in boys and girls with a 
diagnosis of Fragile X syndrome (FXS).  
 
Research Team: Dale Thomas, and Dr Dougal Hare (Cardiff University).  
 
We would like to invite you to take part in our research study. Joining the study is entirely your choice. 
Before you decide to take part, we would like you to understand why the research is being done and 
what it would involve.  
 
What is the purpose of the study? 
 
The purpose and aim of the study are to develop a better understanding of the behaviour exhibited 
by people who have Fragile X syndrome (FXS) when compared to the behavioural phenotype of 
people who have an Autism Spectrum Disorder (ASD) diagnosis.  
 
To better understand FXS, the behaviour traits of boys and girls diagnosed with FXS will be recorded 
by asking parents or carers to complete questionnaires relating to the traits they see. Separate groups 
will be created in order to understand the effects that intellectual disabilities and severity of ASD 
symptoms may have on behaviour for people diagnosed with FXS. This will allow better 
understanding of the similarities and differences in behaviour between people who have been 
diagnosed with FXS when compared to people with an ASD diagnosis.  
 
The study also aims to compare the observable characteristics of boys diagnosed with FXS with that 
of girls diagnosed with FXS. Girls (XX) tend to have a milder presentation of FXS as they have one 
healthy X chromosome alongside the mutated X chromosome. Boys (XY) do not have the extra 
unaffected X chromosome. This appears to result in an increased likelihood of intellectual disabilities. 
Comparing observable traits of boys and girls with FXS will improve our understanding of gender 
differences and enable us to analyse the impact of variables such as degree of intellectual disability 
and autistic traits. 
 
Why have I been invited to take part in this study? 
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You have been invited to take part because you are part of the Fragile X Society research list and have 
previously given your permission to be contacted to take part in research related to FXS. By being on 
this list we have assumed that you are a parent of a child with FXS. We are looking for parents whose 
children are under the age of 16 and have a confirmed diagnosis of FXS who live in the UK.  
 
Do I have to take part? 
 
No, you do not have to take part in the study if you do not want to. Taking part in the research is 
voluntary; this means it is completely up to you to take part. Your decision to participate in this study 
will not be connected to the care you and your family are receiving now or in the future. If you decide 
to take part and sign the consent form but change your mind later, you are free to withdraw at any 
point and do not need to give us a reason. There will not be any consequences to your current or 
future treatment if you decide to do this. 
 
What will participation involve? 
 
• Parents / carers will complete a set of questionnaires, which ask about their demographic 
details, your child’s FXS presentation, if you feel you are receiving the right (or enough) 
support, and if you feel you are receiving the right (or enough) support for your child’s 
education and health needs. Together, these questionnaires will take approximately 30 
minutes to complete. 
• If you are completing paper copies you will be provided with a pre-paid envelope to return 
the questionnaires. 
 
What are the possible disadvantages and risks of taking part?  
 
It is possible that the questionnaires might raise issues that could be distressing to think about. A list 
of agencies and people you can contact is provided should you need any additional 
information/support.  
 
What are the possible benefits of taking part? 
 
The information gained will help services to better understand the needs of a child with FXS and 
identify ways services can help better meet those needs. This will help clinicians to develop 
appropriate support packages, which may help other families in the future. 
 
 
Will my taking part in the study be kept confidential?  
 
Yes. We will handle data sensitively and confidentially and follow legal and ethical guidelines.  
• All data collected about you and your child will be kept strictly confidential and only viewed by 
members of the research team.  It will be stored securely in a locked filing cabinet at the 
University. 
• Data will be entered onto a computer database which will be password protected and 
encrypted.  Each participant will be assigned a number; thus, names will not be entered onto 
the database. 
 144 
• We plan to publish the research and names of participants will not be used. All published data 
will be anonymous. 
 
What if there is a problem? 
 
It is unlikely that anything would go wrong, but if you have a concern about any aspect of the study, 
you should contact one of the researchers. If you are not satisfied and wish to make a formal 
complaint, you can do so through the Cardiff University School Research Ethics Committee 
complaints procedure. Details can be obtained from the University by calling 029 2087 4000. 
In the event that something does go wrong, and you are harmed during the study and this is due to 
somebody’s negligence, then you may have grounds for a legal action for compensation against 
Cardiff University, but you might have to pay your legal costs.  
 
Will I receive any payment for taking part in the study? 
 
Participants will not receive any payment for taking part.  
 
 
Who is organising the research? 
This research is being conducted by Dale Thomas as part of the Doctorate programme in Clinical 
Psychology at Cardiff University. This study will be carried out under the guidance of Dr Dougal Hare 
(Academic Supervisor). It is funded by Cardiff University.  
 
Where will the findings be published? 
• We intend to publish the results in peer-reviewed journals. 
• We intend to present the results at scientific and other relevant conferences. 
• We may put a summary of the findings in the Fragile X Society newsletter. 
• We will provide participants with a summary of the findings if they would like this. 
 
Who has reviewed the study?  
All research in the NHS is looked at by an independent group of people, called a Research Ethics 
Committee who protect the rights, safety, dignity and wellbeing of participants.  This study has been 
reviewed and given a favourable opinion by the Cardiff University School of Psychology Research 
Ethics Committee. 
 
 
Who can I contact for further information? 
 
If you would like to discuss the study or have any questions or concerns, please do not hesitate to 
contact Dale Thomas at thomasdn@cardiff.ac.uk or tel. 02920 870582. Alternatively, you can contact 
Dr Dougal Hare, Department of Clinical Psychology, 11th Floor Tower Building, Park Place, Cardiff 
University, Cardiff CF10 3AT. 
You can keep this copy of the information sheet. 
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Dear  
 
 
Thank you for agreeing to participate in the research that set ‘A comparison of behavioural 
phenotypes of ASD traits in boys and girls with a diagnosis of Fragile X syndrome (FXS’). 
 
This study aimed to better understand what the behavioural presentation (phenotypes) of people with 
Fragile X Syndrome (FXS) looks like and how that differs from Autistic Spectrum Condition (ASC) 
by asking you to complete questionnaires relating to the traits that you see. The research study used 
this data to: 
 
• Assess the severity of Autistic symptoms for people diagnosed with FXS 
• Assess the impact of intellectual disabilities on FXS (for those who experience both) 
• Compare the behavioural presentation of males diagnosed with FXS with that of females 
diagnosed with FXS 
 
The findings from this research may help inform ways of better supporting people with FXS and 
their families in the future, for example, by tailoring psychological interventions to better met their 
needs. 
 
All the data we collected for this study is confidential, all personal and identifiable information will 
be kept anonymous and only the researcher and relevant members of the research team can access it.  
 
If you have any questions, queries or require further support please email me at 
thomasdn@cardiff.ac.uk or phone me on 02920870582. Alternatively, you can contact my 
supervisor, Dr Dougal Hare on the above telephone number or email address hared@cardiff.ac.uk . 
 
 
This study relied on your participation and time which is greatly appreciated, thank-you again for 
your support. 
 
 
Yours sincerely, 
 
 
Dale Thomas 
Trainee Clinical Psychologist 
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Consent Form                             
Participant ID: _____ 
Title of Project: A comparison of behavioural phenotypes of ASD traits in boys and girls with a 
diagnosis of Fragile X syndrome (FXS).  
Name of Researcher: Dale Thomas 
 
Cardiff University in collaboration with the Fragile X Society  
                                                                                                                                                                                                                                                  
Please tick 
as appropriate 
1 
I confirm that I have read the information sheet dated.................... 
(version............) for the above study. I have had the opportunity to consider 
the information, ask questions and have had these answered satisfactorily. 
 
2 
I understand that my participation is voluntary and that I am free to withdraw 
at any time 
without giving any reason, without my medical care or legal rights being 
affected, up until 
the research data has been analysed. 
 
3 
I understand that data collected during the study may be looked at by 
individuals from Cardiff University where it is relevant to my taking part in 
this research. I give permission for these individuals to have access to my 
data. 
 
4 
I understand my participation is anonymous and my confidentiality will be 
upheld at all time.   
5 I agree to take part in the above study.  
 
Name of Participant (Parent): ______________________    
Participant Signature: ____________________ 
Date ______________ 
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psychethics	
• Dale	Thomas;	
• 	Dougal	Hare	
 	
Dear Dale, 
  
The Ethics Committee has considered your PG project proposal: A comparison of behavioural phenotypes of 
ASD traits in males and females with a diagnosis of Fragile X syndrome (FXS) (EC.19.01.08.5553). 
                                                                                                                                                                             
The project has been approved. 
  
Please note that if any changes are made to the above project then you must notify the Ethics Committee. 
  
  Best	wishes, Adam	Hammond 	 
School	of	Psychology	Research	Ethics	Committee 
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